<!DOCTYPE html>
<html lang="en" dir="ltr" 
  xmlns="http://www.w3.org/1999/xhtml"
  xmlns:mml="http://www.w3.org/1998/Math/MathML">
  <head prefix="og: http://ogp.me/ns# article: http://ogp.me/ns/article# book: http://ogp.me/ns/book#" >
    <!--[if IE]><![endif]-->
<link rel="dns-prefetch" href="//d33xdlntwy0kbs.cloudfront.net" />
<link rel="dns-prefetch" href="//www.google.com" />
<link rel="dns-prefetch" href="//scholar.google.com" />
<link rel="dns-prefetch" href="//www.google-analytics.com" />
<link rel="dns-prefetch" href="//stats.g.doubleclick.net" />
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="viewport" content="width=device-width, initial-scale=1" />
<link rel="shortcut icon" href="https://www.medrxiv.org/sites/default/files/images/favicon.ico" type="image/vnd.microsoft.icon" />
<link rel="alternate" type="application/pdf" title="Full Text (PDF)" href="/content/10.1101/2021.10.25.21265462v1.full.pdf" />
<link rel="alternate" type="text/plain" title="Full Text (Plain)" href="/content/10.1101/2021.10.25.21265462v1.full.txt" />
<link rel="alternate" type="application/vnd.ms-powerpoint" title="Powerpoint" href="/content/10.1101/2021.10.25.21265462v1.ppt" />
<meta name="type" content="article" />
<meta name="category" content="article" />
<meta name="HW.identifier" content="/medrxiv/early/2021/10/26/2021.10.25.21265462.atom" />
<meta name="HW.pisa" content="medrxiv;2021.10.25.21265462v1" />
<meta name="DC.Format" content="text/html" />
<meta name="DC.Language" content="en" />
<meta name="DC.Title" content="REcovery and SURvival of patients with moderate to severe acute REspiratory distress syndrome (ARDS) due to COVID-19: a multicentre, single-arm, Phase IV Itolizumab Trial: RESURRECT" />
<meta name="DC.Identifier" content="10.1101/2021.10.25.21265462" />
<meta name="DC.Date" content="2021-10-26" />
<meta name="DC.Publisher" content="Cold Spring Harbor Laboratory Press" />
<meta name="DC.Rights" content="© 2021, Posted by Cold Spring Harbor Laboratory. The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission." />
<meta name="DC.AccessRights" content="restricted" />
<meta name="DC.Description" content="Objective To evaluate safety and efficacy of Itolizumab in hospitalized COVID-19 patients with PaO2/FiO2 ratio (PFR) ≤200 requiring oxygen therapy.

Design A multicentre, single-arm, Phase-4 study with a treatment period of 30-Days and an extended follow-up period of 90-Days.

Methods Hospitalized adult patients (n=300) with SARS-CoV-2 infection, with PFR ≤200; oxygen saturation ≤94% and ≥1 elevated inflammatory markers were included from 17 COVID-19-specific tertiary hospitals in India. Patients received Itolizumab infusion 1.6 mg/kg and were assessed for 1-month and then followed up to Day-90.

Results Day-30 post-treatment safety/efficacy results and Day-90 mortality results are presented. Primary outcome measures: incidence of severe acute infusion-related reactions (IRRs) (≥Grade-3) was 1.3% and mortality rate at 1-month was 6.7% (n=20/300). Key secondary analyses: Mortality rate at Day-90 was 8.0% (24/300). 91.7% patients came off the oxygen therapy within Day-30 of treatment. By Day-7, most patients had stable/improved SpO2 without increasing FiO2. Mean PFR improved by 50% by Day-7 (p&lt;0.001) and the trend remained consistent till Day-30. Median time of recovery was 8 days. Cumulatively, at Day-30, 260(86.7%), 256(85.3%), 132(44.0%), 113(37.6%) and 32(10.7%) patients showed &gt;1-point, &gt;2-point, &gt;3-point, &gt;4-point and 5-point improvement on the modified COVID-19 8-point ordinal scale and worsening of symptoms by &gt;1 point, &gt;2 points and 3-points was seen in 26(8.7%), 20(6.7%) and 6(2.0%) patients, respectively. CRP, D-dimer, LDH, and serum ferritin levels significantly decreased (p≤0.01) compared with baseline. IL-6 and TNFα levels also decreased 48-hours post-infusion. Overall, 123 treatment-emergent adverse events (TEAEs) were reported in 63 patients, most being Grades 1-3. Most common TEAEs were IRRs and lymphopenia; most common serious TEAEs were septic shock, worsening of ARDS, and respiratory failure. No deaths were attributable to Itolizumab.

Conclusion Itolizumab shows no new safety concerns and suggests a mortality and recovery benefit at 1-month in hospitalized COVID-19 patients requiring oxygen therapy.

Trial registry number CTRI/2020/09/027941

### Competing Interest Statement

Drs Raveendra KR, Chirag Rathod and Rahul Darnule received funding for the study and professional fees as Principal Investigators from Biocon Biologics Limited. All other authors are employees of Biocon Biologics Limited and may be eligible for stock and stock options.

### Clinical Trial

CTRI/2020/09/027941

### Funding Statement

This study was funded by Biocon Biologics Limited

### Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Institutional Ethics Committee of Govt. Medical College and Hospital, Nagpur gave ethical approval for this work Institutional Ethics Committee of SRM Institutes for Medical Science, Chennai gave ethical approval for this work

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

All data produced in the present study are available upon reasonable request to the authors" />
<meta name="DC.Contributor" content="KR Raveendra" />
<meta name="DC.Contributor" content="Chirag Rathod" />
<meta name="DC.Contributor" content="Rahul Darnule" />
<meta name="DC.Contributor" content="Subramanian Loganathan" />
<meta name="DC.Contributor" content="Sarika Deodhar" />
<meta name="DC.Contributor" content="A Radhika" />
<meta name="DC.Contributor" content="Ashwani Marwah" />
<meta name="DC.Contributor" content="Nitin M Chaudhari" />
<meta name="DC.Contributor" content="Binay K Thakur" />
<meta name="DC.Contributor" content="Sivakumar Vaidyanathan" />
<meta name="DC.Contributor" content="Sandeep Nilkanth Athalye" />
<meta name="article:published_time" content="2021-10-26" />
<meta name="citation_title" content="REcovery and SURvival of patients with moderate to severe acute REspiratory distress syndrome (ARDS) due to COVID-19: a multicentre, single-arm, Phase IV Itolizumab Trial: RESURRECT" />
<meta name="citation_abstract" lang="en" content="&lt;p&gt;&lt;b&gt;Objective&lt;/b&gt;: To evaluate safety and efficacy of Itolizumab in hospitalized COVID-19 patients with PaO&lt;sub&gt;2&lt;/sub&gt;/FiO&lt;sub&gt;2&lt;/sub&gt; ratio (PFR) ≤200 requiring oxygen therapy.
&lt;b&gt;Design&lt;/b&gt;: A multicentre, single-arm, Phase-4 study with a treatment period of 30-Days and an extended follow-up period of 90-Days.  
&lt;b&gt;Methods&lt;/b&gt;: Hospitalized adult patients (n=300) with SARS-CoV-2 infection, with PFR ≤200, oxygen saturation ≤94% and ≥1 elevated inflammatory markers were included from 17 COVID-19 specific tertiary hospitals in India. Patients received Itolizumab infusion 1.6 mg/kg and were assessed for 1-month and then followed up to Day-90.
&lt;b&gt;Results&lt;/b&gt;: Day-30 post-treatment safety/efficacy results and Day-90 mortality results are presented. Primary outcome measures: incidence of severe acute infusion-related reactions (IRRs) (≥Grade-3) was 1.3% and mortality rate at 1-month was 6.7% (n=20/300). Key secondary analyses: Mortality rate at Day-90 was 8.0% (24/300). 91.7% patients came off the oxygen therapy within Day-30 of treatment. By Day-7, most patients had stable/improved SpO&lt;sub&gt;2&lt;/sub&gt; without increasing FiO&lt;sub&gt;2&lt;/sub&gt;. Mean PFR improved by 50% by Day-7 (p&amp;lt;0.001) and the trend remained consistent till Day-30. Median time of recovery was 8 days. Cumulatively, at Day-30, 260(86.7%), 256(85.3%), 132(44.0%), 113(37.6%) and 32(10.7%) patients showed &amp;gt;1-point, &amp;gt;2-point, &amp;gt;3-point, &amp;gt;4-point and 5-point improvement on the modified COVID-19 8-point ordinal scale and worsening of symptoms by &amp;gt;1 point, &amp;gt;2 points and 3-points was seen in 26(8.7%), 20(6.7%) and 6(2.0%) patients, respectively. CRP, D-dimer, LDH and serum ferritin levels significantly decreased (p≤0.01) compared with baseline. IL-6 and TNFα levels also decreased 48-hours post-infusion. Overall, 123 treatment-emergent adverse events (TEAEs) were reported in 63 patients, most being Grades 1-3. Most common TEAEs were IRRs and lymphopenia; most common serious TEAEs were septic shock, worsening of ARDS and respiratory failure. No deaths were attributable to Itolizumab.
&lt;b&gt;Conclusion&lt;/b&gt;: Itolizumab shows no new safety concerns and suggests a mortality and recovery benefit at 1-month in hospitalized COVID-19 patients requiring oxygen therapy.&lt;/p&gt;" />
<meta name="citation_journal_title" content="medRxiv" />
<meta name="citation_publisher" content="Cold Spring Harbor Laboratory Press" />
<meta name="citation_publication_date" content="2021/01/01" />
<meta name="citation_mjid" content="medrxiv;2021.10.25.21265462v1" />
<meta name="citation_id" content="2021.10.25.21265462v1" />
<meta name="citation_public_url" content="https://www.medrxiv.org/content/10.1101/2021.10.25.21265462v1" />
<meta name="citation_abstract_html_url" content="https://www.medrxiv.org/content/10.1101/2021.10.25.21265462v1.abstract" />
<meta name="citation_full_html_url" content="https://www.medrxiv.org/content/10.1101/2021.10.25.21265462v1.full" />
<meta name="citation_pdf_url" content="https://www.medrxiv.org/content/medrxiv/early/2021/10/26/2021.10.25.21265462.full.pdf" />
<meta name="citation_doi" content="10.1101/2021.10.25.21265462" />
<meta name="citation_num_pages" content="32" />
<meta name="citation_article_type" content="Article" />
<meta name="citation_firstpage" content="2021.10.25.21265462" />
<meta name="citation_author" content="KR Raveendra" />
<meta name="citation_author_institution" content="Victoria Hospital, Bangalore Medical College and Research Institute" />
<meta name="citation_author" content="Chirag Rathod" />
<meta name="citation_author_institution" content="GMERS Medical College &amp; Hospital" />
<meta name="citation_author" content="Rahul Darnule" />
<meta name="citation_author_institution" content="Saint George’s Hospital" />
<meta name="citation_author" content="Subramanian Loganathan" />
<meta name="citation_author_institution" content="Clinical Development and Medical Affairs" />
<meta name="citation_author_email" content="subramanian.l101@biocon.com" />
<meta name="citation_author_orcid" content="http://orcid.org/0000-0001-7186-0049" />
<meta name="citation_author" content="Sarika Deodhar" />
<meta name="citation_author_institution" content="Clinical Development and Medical Affairs" />
<meta name="citation_author" content="A Radhika" />
<meta name="citation_author_institution" content="Clinical Development and Medical Affairs" />
<meta name="citation_author" content="Ashwani Marwah" />
<meta name="citation_author_institution" content="Clinical Development and Medical Affairs" />
<meta name="citation_author" content="Nitin M Chaudhari" />
<meta name="citation_author_institution" content="Clinical Development and Medical Affairs" />
<meta name="citation_author" content="Binay K Thakur" />
<meta name="citation_author_institution" content="Clinical Development and Medical Affairs" />
<meta name="citation_author" content="Sivakumar Vaidyanathan" />
<meta name="citation_author_institution" content="Clinical Development and Medical Affairs" />
<meta name="citation_author" content="Sandeep Nilkanth Athalye" />
<meta name="citation_author_institution" content="Clinical Development and Medical Affairs" />
<meta name="citation_reference" content="Johns Hopkins CSSE. Coronavirus (COVID-19) global cases: centre for systems science and engineering, Johns Hopkins University. 2020. Available: https://coronavirus.jhu.edu/map.html [Accessed 22 Oct 2021]." />
<meta name="citation_reference" content="Coperchini F, Chiovato L, Croce L, et al. The cytokine storm in COVID-19: an overview of the involvement of the chemokine/chemokine receptor system. Cytokine Growth Factor Rev 2020;53:25–32.doi:10.1016/j.cytogfr.2020.05.003." />
<meta name="citation_reference" content="Tay MZ, Poh CM, Rénia L, et al. The trinity of COVID-19: immunity, inflammation, and intervention. Nat Rev Immunol 2020;20:363–74.doi:10.1038/s41577-020-0311-8." />
<meta name="citation_reference" content="Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497–506.doi:10.1016/S0140-6736(20)30183-5." />
<meta name="citation_reference" content="Kadhim AS, Abdullah YJ. Serum levels of interleukin–6, ferritin, C-reactive protein, lactate dehydrogenase, D-dimer and count of lymphocytes and neutrophils in COVID-19 patients: its correlation to the disease severity. Biomed Biotech Res J 2021;5:69–73.doi:10.4103/bbrj.bbrj_188_20." />
<meta name="citation_reference" content="Marovich M, Mascola JR, Cohen MS. Monoclonal antibodies for prevention and treatment of COVID-19. J Am Med Assoc 2020;324: 131–2.doi: 10.1001/jama.2020.10245." />
<meta name="citation_reference" content="Narain S, Stefanov DG, Chau AS, et al. Comparative survival analysis of immunomodulatory therapy for coronavirus disease 2019 cytokine storm. Chest 2021;159: 933–48.doi:10.1016/j.chest.2020.09.275." />
<meta name="citation_reference" content="Rizk JG, Kalantar-Zadeh K, Mehra MR, et al. Pharmaco-immunomodulatory therapy in COVID-19. Drugs 2020;80: 1267–92.doi:10.1007/s40265-020-01367-z." />
<meta name="citation_reference" content="Kumar S, De Souza R, Nadkar M, et al. A two-arm, randomized, controlled, multicentric, open-label Phase-2 study to evaluate the efficacy and safety of Itolizumab in moderate to severe ARDS patients due to COVID-19. Expert Opin Biol Ther 2021;21: 675–86.doi:10.1080/14712598.2021.1905794." />
<meta name="citation_reference" content="Bughani U, Saha A, Kuriakose A, et al. T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab. PLoS One 2017;12: e0180088.doi:10.1371/journal.pone.0180088." />
<meta name="citation_reference" content="Li Y, Singer NG, Whitbred J, et al. CD6 as a potential target for treating multiple sclerosis. Proc Nat Acad Sci 2017;114: 2687–92.doi:10.1073/pnas.1615253114." />
<meta name="citation_reference" content="Loganathan S, Athalye SN, Joshi SR. Itolizumab, an anti-CD6 monoclonal antibody, as a potential treatment for COVID-19 complications. Expert Opin Biol Ther 2020;20:1025–31.doi:10.1080/14712598.2020.1798399." />
<meta name="citation_reference" content="Nair P, Melarkode R, Rajkumar D, et al. CD6 synergistic co-stimulation promoting proinflammatory response is modulated without interfering with the activated leukocyte cell adhesion molecule interaction. Clin Exp Immunol 2010;162:116–30.doi:10.1111/j.1365-2249.2010.04235.x." />
<meta name="citation_reference" content="Menon R, David BG. Itolizumab - a humanized anti-CD6 monoclonal antibody with a better side effects profile for the treatment of psoriasis. Clin Cosmet Investig Dermatol 2015;8:215–22.doi:10.2147/CCID.S47784." />
<meta name="citation_reference" content="Krupashankar DS, Dogra S, Kura M, et al. Efficacy and safety of Itolizumab, a novel anti-CD6 monoclonal antibody, in patients with moderate to severe chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, phase-III study. J Am Acad Dermatol 2014;71:484–92.doi:10.1016/j.jaad.2014.01.897." />
<meta name="citation_reference" content="Dogra S, Krupashankar DS, Budamakuntla L, et al. Long-term efficacy and safety of Itolizumab in patients with moderate-to-severe chronic plaque psoriasis: a doubleblind, randomized withdrawal, placebo-controlled study. J Am Acad Dermatol 2015;73: 331–3.e1.doi:10.1016/j.jaad.2015.03.040." />
<meta name="citation_reference" content="Saavedra D, Añé-Kourí AL, Sánchez N, et al. An anti-CD6 monoclonal antibody (Itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients. Immun Ageing 2020;17:34.doi:10.1186/s12979-020-00207-8." />
<meta name="citation_reference" content="Filgueira LM, Cervantes JB, Lovelle OA, et al. An anti-CD6 antibody for the treatment of COVID-19 patients with cytokine-release syndrome: report of three cases. Immunotherapy 2021;13:289–95.doi:10.2217/imt-2020-0235." />
<meta name="citation_reference" content="Díaz Y, Ramos-Suzarte M, Martín Y, et al. Use of a humanized anti-CD6 monoclonal antibody (Itolizumab) in elderly patients with moderate COVID-19. Gerontology 2020;66:553–61.doi:10.1159/000512210." />
<meta name="citation_reference" content="Gore V, Kshirsagar DP, Bhat SM, et al. Itolizumab treatment for cytokine release syndrome in moderate to severe acute respiratory distress syndrome due to COVID-19: clinical outcomes, a retrospective study. J Assoc Physicians India 2021;69:13–8." />
<meta name="citation_reference" content="Thacker HP, Dhekane A, Wadhwa N, et al. Anti-CD6 humanized monoclonal antibody Itolizumab, halts disease progression and severity of acute respiratory distress syndrome in COVID-19 disease: a case study. Indian J Resp Care 2021;10:112–5.doi:10.4103/ijrc.ijrc_78_20." />
<meta name="citation_reference" content="Thacker HP, Dhekane A, Wadhwa N, et al. An early experience of Itolizumab with best supportive care in the treatment of moderate to severe COVID-19 patients: a retrospective study. Indian J Immun Resp Med 2020;6:24–8. doi:10.18231/j.ijirm.2021.005." />
<meta name="citation_reference" content="https://www.biocon.com/docs/Biocon_Annual_Report_2021.pdf [Accessed 22 Oct 2021]." />
<meta name="citation_reference" content="Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the treatment of Covid-19: final report. N Engl J Med 2020;383:1813–26.doi:10.1056/NEJMoa2007764." />
<meta name="citation_reference" content="RECOVERY Collaborative Group. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet 2021;397:1637–45.doi:10.1016/S0140-6736(21)00676-0." />
<meta name="citation_reference" content="Budhiraja S, Soni A, Jha V, et al. 2020. Clinical profile of first 1000 COVID-19 cases admitted at tertiary care hospitals and the correlates of their mortality: an Indian experience. MedRxiv doi:https://doi.org/10.1101/2020.11.16.20232223." />
<meta name="citation_reference" content="Malhotra V, Basu S, Sharma N, et al. Outcomes among 10,314 hospitalized COVID-19 patients at a tertiary care government hospital in Delhi, India. J Med Virol 2021;93:4553–8.doi:10.1002/jmv.26956.u." />
<meta name="citation_reference" content="Mahale N, Rajhans P, Godavarthy P, et al. A retrospective observational study of hypoxic COVID-19 patients treated with immunomodulatory drugs in a tertiary care hospital. Indian J Crit Care Med 2020;24:1020–7.doi:10.5005/jp-journals-10071-23599." />
<meta name="citation_reference" content="Kumari P, Kumar A, Sinha C, et al. Off-label use of Itolizumab in patients with COVID-19 ARDS: our clinical experience in a dedicated COVID centre. Ind J Crit Care Med 2021;25:467–9.doi:10.5005/jp-journals-10071-23787." />
<meta name="citation_reference" content="Goyal A, Saigal S, Joshi A, et al. 2020. Whether early steroid dose is associated with lower mortality in COVID-19 critically ill patients-an exploratory chart review. MedRxiv doi:https://doi.org/10.1101/2020.08.19.20171868." />
<meta name="citation_reference" content="Bobdey S, Chawla N, Behera V, et al. An analysis of mortality and survival of COVID 19 patients admitted to a tertiary care hospital in Maharashtra, India. Med J Armed Forces India 2021;77:S353–8.doi:10.1016/j.mjafi.2021.02.004." />
<meta name="citation_reference" content="Rosas IO, Bräu N, Waters M, et al. Tocilizumab in hospitalized patients with severe Covid-19 pneumonia. N Engl J Med 2021;384:1503–16.doi:10.1056/NEJMoa2028700." />
<meta name="citation_reference" content="Henry BM, de Oliveira MHS, Benoit S, et al. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med 2020;58:1021–8.doi:10.1515/cclm-2020-0369." />
<meta name="citation_reference" content="Tang Y, Liu J, Zhang D, et al. Cytokine storm in COVID-19: the current evidence and treatment strategies. Front Immunol 2020;11:1708.doi:10.3389/fimmu.2020.01708." />
<meta name="citation_reference" content="Uettwiller F, Rigal E, Hoarau C. Infections associated with monoclonal antibody and fusion protein therapy in humans. mAbs 2011;3:461–6.doi:10.4161/mabs.3.5.16553." />
<meta name="citation_reference" content="Toniati P, Piva S, Cattalini M, et al. Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single centre study of 100 patients in Brescia, Italy. Autoimmun Rev 2020;19:102568.doi:10.1016/j.autrev.2020.102568." />
<meta name="citation_reference" content="Elezkurtaj S, Greuel S, Ihlow Jana, et al. Causes of death and comorbidities in hospitalized patients with COVID-19. Sci Rep 2021;11:4263.doi:10.1038/s41598-021-82862-5." />
<meta name="citation_reference" content="Grein J, Ohmagari N, Shin D, et al. Compassionate use of Remdesivir for patients with severe Covid-19. N Engl J Med 2020;382:2327–36.doi:10.1056/NEJMoa2007016." />
<meta name="citation_reference" content="Salama C, Han J, Yau L, et al. Tocilizumab in patients hospitalized with Covid-19 pneumonia. N Engl J Med 2021;384:20–30.doi:10.1056/NEJMoa2030340." />
<meta name="twitter:title" content="REcovery and SURvival of patients with moderate to severe acute REspiratory distress syndrome (ARDS) due to COVID-19: a multicentre, single-arm, Phase IV Itolizumab Trial: RESURRECT" />
<meta name="twitter:site" content="@medrxivpreprint" />
<meta name="twitter:card" content="summary" />
<meta name="twitter:description" content="Objective To evaluate safety and efficacy of Itolizumab in hospitalized COVID-19 patients with PaO2/FiO2 ratio (PFR) ≤200 requiring oxygen therapy.

Design A multicentre, single-arm, Phase-4 study with a treatment period of 30-Days and an extended follow-up period of 90-Days.

Methods Hospitalized adult patients (n=300) with SARS-CoV-2 infection, with PFR ≤200; oxygen saturation ≤94% and ≥1 elevated inflammatory markers were included from 17 COVID-19-specific tertiary hospitals in India. Patients received Itolizumab infusion 1.6 mg/kg and were assessed for 1-month and then followed up to Day-90.

Results Day-30 post-treatment safety/efficacy results and Day-90 mortality results are presented. Primary outcome measures: incidence of severe acute infusion-related reactions (IRRs) (≥Grade-3) was 1.3% and mortality rate at 1-month was 6.7% (n=20/300). Key secondary analyses: Mortality rate at Day-90 was 8.0% (24/300). 91.7% patients came off the oxygen therapy within Day-30 of treatment. By Day-7, most patients had stable/improved SpO2 without increasing FiO2. Mean PFR improved by 50% by Day-7 (p&lt;0.001) and the trend remained consistent till Day-30. Median time of recovery was 8 days. Cumulatively, at Day-30, 260(86.7%), 256(85.3%), 132(44.0%), 113(37.6%) and 32(10.7%) patients showed &gt;1-point, &gt;2-point, &gt;3-point, &gt;4-point and 5-point improvement on the modified COVID-19 8-point ordinal scale and worsening of symptoms by &gt;1 point, &gt;2 points and 3-points was seen in 26(8.7%), 20(6.7%) and 6(2.0%) patients, respectively. CRP, D-dimer, LDH, and serum ferritin levels significantly decreased (p≤0.01) compared with baseline. IL-6 and TNFα levels also decreased 48-hours post-infusion. Overall, 123 treatment-emergent adverse events (TEAEs) were reported in 63 patients, most being Grades 1-3. Most common TEAEs were IRRs and lymphopenia; most common serious TEAEs were septic shock, worsening of ARDS, and respiratory failure. No deaths were attributable to Itolizumab.

Conclusion Itolizumab shows no new safety concerns and suggests a mortality and recovery benefit at 1-month in hospitalized COVID-19 patients requiring oxygen therapy.

Trial registry number CTRI/2020/09/027941

### Competing Interest Statement

Drs Raveendra KR, Chirag Rathod and Rahul Darnule received funding for the study and professional fees as Principal Investigators from Biocon Biologics Limited. All other authors are employees of Biocon Biologics Limited and may be eligible for stock and stock options.

### Clinical Trial

CTRI/2020/09/027941

### Funding Statement

This study was funded by Biocon Biologics Limited

### Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Institutional Ethics Committee of Govt. Medical College and Hospital, Nagpur gave ethical approval for this work Institutional Ethics Committee of SRM Institutes for Medical Science, Chennai gave ethical approval for this work

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

All data produced in the present study are available upon reasonable request to the authors" />
<meta name="og-title" property="og:title" content="REcovery and SURvival of patients with moderate to severe acute REspiratory distress syndrome (ARDS) due to COVID-19: a multicentre, single-arm, Phase IV Itolizumab Trial: RESURRECT" />
<meta name="og-url" property="og:url" content="https://www.medrxiv.org/content/10.1101/2021.10.25.21265462v1" />
<meta name="og-site-name" property="og:site_name" content="medRxiv" />
<meta name="og-description" property="og:description" content="Objective To evaluate safety and efficacy of Itolizumab in hospitalized COVID-19 patients with PaO2/FiO2 ratio (PFR) ≤200 requiring oxygen therapy.

Design A multicentre, single-arm, Phase-4 study with a treatment period of 30-Days and an extended follow-up period of 90-Days.

Methods Hospitalized adult patients (n=300) with SARS-CoV-2 infection, with PFR ≤200; oxygen saturation ≤94% and ≥1 elevated inflammatory markers were included from 17 COVID-19-specific tertiary hospitals in India. Patients received Itolizumab infusion 1.6 mg/kg and were assessed for 1-month and then followed up to Day-90.

Results Day-30 post-treatment safety/efficacy results and Day-90 mortality results are presented. Primary outcome measures: incidence of severe acute infusion-related reactions (IRRs) (≥Grade-3) was 1.3% and mortality rate at 1-month was 6.7% (n=20/300). Key secondary analyses: Mortality rate at Day-90 was 8.0% (24/300). 91.7% patients came off the oxygen therapy within Day-30 of treatment. By Day-7, most patients had stable/improved SpO2 without increasing FiO2. Mean PFR improved by 50% by Day-7 (p&lt;0.001) and the trend remained consistent till Day-30. Median time of recovery was 8 days. Cumulatively, at Day-30, 260(86.7%), 256(85.3%), 132(44.0%), 113(37.6%) and 32(10.7%) patients showed &gt;1-point, &gt;2-point, &gt;3-point, &gt;4-point and 5-point improvement on the modified COVID-19 8-point ordinal scale and worsening of symptoms by &gt;1 point, &gt;2 points and 3-points was seen in 26(8.7%), 20(6.7%) and 6(2.0%) patients, respectively. CRP, D-dimer, LDH, and serum ferritin levels significantly decreased (p≤0.01) compared with baseline. IL-6 and TNFα levels also decreased 48-hours post-infusion. Overall, 123 treatment-emergent adverse events (TEAEs) were reported in 63 patients, most being Grades 1-3. Most common TEAEs were IRRs and lymphopenia; most common serious TEAEs were septic shock, worsening of ARDS, and respiratory failure. No deaths were attributable to Itolizumab.

Conclusion Itolizumab shows no new safety concerns and suggests a mortality and recovery benefit at 1-month in hospitalized COVID-19 patients requiring oxygen therapy.

Trial registry number CTRI/2020/09/027941

### Competing Interest Statement

Drs Raveendra KR, Chirag Rathod and Rahul Darnule received funding for the study and professional fees as Principal Investigators from Biocon Biologics Limited. All other authors are employees of Biocon Biologics Limited and may be eligible for stock and stock options.

### Clinical Trial

CTRI/2020/09/027941

### Funding Statement

This study was funded by Biocon Biologics Limited

### Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Institutional Ethics Committee of Govt. Medical College and Hospital, Nagpur gave ethical approval for this work Institutional Ethics Committee of SRM Institutes for Medical Science, Chennai gave ethical approval for this work

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

All data produced in the present study are available upon reasonable request to the authors" />
<meta name="og-type" property="og:type" content="article" />
<meta name="og-image" property="og:image" content="" />
<meta name="citation_date" content="2021-10-26" />
<meta name="description" content="medRxiv - The Preprint Server for Health Sciences" />
<meta name="generator" content="Drupal 7 (http://drupal.org)" />
<link rel="canonical" href="https://www.medrxiv.org/content/10.1101/2021.10.25.21265462v1" />
<link rel="shortlink" href="https://www.medrxiv.org/node/426620" />
    <title>REcovery and SURvival of patients with moderate to severe acute REspiratory distress syndrome (ARDS) due to COVID-19: a multicentre, single-arm, Phase IV Itolizumab Trial: RESURRECT | medRxiv</title>  
    <link type="text/css" rel="stylesheet" href="https://www.medrxiv.org/sites/default/files/advagg_css/css__7SC0i-kTgUlQGKuqbmyS18Sez8FDO-aG9FSHkGrLGl8__9Xf-fJpmF9h8tvWywQTaOzJzFLt4sEfx108Wh1gYmm0__OWu9jWxbqz5eMqeTDc4xZhOzPlgoEqGh5PmxOqlf8ZY.css" media="all" />
<link type="text/css" rel="stylesheet" href="//cdn.jsdelivr.net/qtip2/2.2.1/jquery.qtip.min.css" media="all" />
<link type="text/css" rel="stylesheet" href="https://www.medrxiv.org/sites/default/files/advagg_css/css__6CA0-YpwAeHt1tcr6dmX5ZBUuxlddlGnE8FCmWRwxOw__M2jATP9fgS6Hut-L0G3s312CoMA5SDjnuWFM3KPLIRs__OWu9jWxbqz5eMqeTDc4xZhOzPlgoEqGh5PmxOqlf8ZY.css" media="all" />
<style type="text/css" media="all">
/* <![CDATA[ */
#sliding-popup.sliding-popup-bottom,#sliding-popup.sliding-popup-bottom .eu-cookie-withdraw-banner,.eu-cookie-withdraw-tab{background:gray}#sliding-popup.sliding-popup-bottom.eu-cookie-withdraw-wrapper{background:transparent}#sliding-popup .popup-content #popup-text h1,#sliding-popup .popup-content #popup-text h2,#sliding-popup .popup-content #popup-text h3,#sliding-popup .popup-content #popup-text p,.eu-cookie-compliance-secondary-button,.eu-cookie-withdraw-tab{color:#fff !important}.eu-cookie-withdraw-tab{border-color:#fff}.eu-cookie-compliance-more-button{color:#fff !important}
/* ]]> */
</style>

<!--[if lte IE 7]>
<link type="text/css" rel="stylesheet" href="https://www.medrxiv.org/sites/default/files/advagg_css/css__ElJr3PIJEvw3qLXc1cnYiLj2G4KgDPSXFOfm6Phf8hw__JdWGm15cDWjsK6KrFlQVXQix9YgNeYysf22XZHj-Y-c__OWu9jWxbqz5eMqeTDc4xZhOzPlgoEqGh5PmxOqlf8ZY.css" media="all" />
<![endif]-->
<link type="text/css" rel="stylesheet" href="https://www.medrxiv.org/sites/default/files/advagg_css/css__Wnlyen9qEpwh_Qaf9okEu4QdVGM0BDothxeqA6Nbvo8__EJmw6SZD9bYoS8jocCpPYS3JFRURpdzmuvJoAUNiI-g__OWu9jWxbqz5eMqeTDc4xZhOzPlgoEqGh5PmxOqlf8ZY.css" media="all" />
<link type="text/css" rel="stylesheet" href="https://www.medrxiv.org/sites/default/files/advagg_css/css__XPg6Aobs217v0T9rA_Y-wMrH3jyqmqunImGwMN4WMEE__Nc8_6i0mjd_g-hzHvpxLmo5g2aluEkJf5SXcEKb7YRY__OWu9jWxbqz5eMqeTDc4xZhOzPlgoEqGh5PmxOqlf8ZY.css" media="all" />

<!--[if (lt IE 9)&(!IEMobile)]>
<link type="text/css" rel="stylesheet" href="https://www.medrxiv.org/sites/default/files/advagg_css/css__XH6bpcI0f2dImc-p674DLCZtWBGb-QwxJK1YexVGtno__vUceGprdo5nIhV6DH93X7fI3r8RcTJbChbas9TQXeW4__OWu9jWxbqz5eMqeTDc4xZhOzPlgoEqGh5PmxOqlf8ZY.css" media="all" />
<![endif]-->

<!--[if gte IE 9]><!-->
<link type="text/css" rel="stylesheet" href="https://www.medrxiv.org/sites/default/files/advagg_css/css__2WBMox6sOrN42ss5lCnH7WWVRdFdJCxtTKnQJYRwTE4__yqNvNYLvMpjy3ffuJrjjm9uW2i-Me1c23KLYuWHaqio__OWu9jWxbqz5eMqeTDc4xZhOzPlgoEqGh5PmxOqlf8ZY.css" media="all" />
<!--<![endif]-->
<link type="text/css" rel="stylesheet" href="https://www.medrxiv.org/sites/default/files/advagg_css/css__GJ_y0JYBjHihOcdJg-wLEQWRfqvBxU74PCdjUcUHlyY__f0nQteVSjWTKq2ga8E2qYttGognShmPZZJdeGhQoNFI__OWu9jWxbqz5eMqeTDc4xZhOzPlgoEqGh5PmxOqlf8ZY.css" media="all" />
<link type="text/css" rel="stylesheet" href="https://d33xdlntwy0kbs.cloudfront.net/cshl_custom_medrxiv.css" media="all" />
    <script type="text/javascript" src="https://www.medrxiv.org/sites/default/files/advagg_js/js__BKYqkKToQ7EjirB7eIdMEH5521EU3da9IpoOs8Ex2XI__aSjVoX8giBmLhN2EbCgIGQJNu89Mh5aVu1LvI_gkJ7Y__OWu9jWxbqz5eMqeTDc4xZhOzPlgoEqGh5PmxOqlf8ZY.js"></script>
<script type="text/javascript" src="//cdn.jsdelivr.net/qtip2/2.2.1/jquery.qtip.min.js"></script>
<script type="text/javascript" src="https://www.medrxiv.org/sites/default/files/advagg_js/js__4Cn2dxvNlsJ-sHe6QOTLREaQvcqb0Yh0Zm9tTOHtQow__DGggC5UtYkPCwIH8nsa7Vw7hug93fb9QVVl0UJ3mfMM__OWu9jWxbqz5eMqeTDc4xZhOzPlgoEqGh5PmxOqlf8ZY.js"></script>
<script type="text/javascript" src="https://www.google.com/recaptcha/api.js?hl=en&amp;render=explicit&amp;onload=drupalRecaptchaOnload"></script>
<script type="text/javascript" src="https://www.medrxiv.org/sites/default/files/advagg_js/js__dGWpV57YWu3sX6UOe04RMH-iP9jSkEP7Ajt0caYXZZk__sUEhH4BzLc9Xn679uyzc7yvwgMkxjsks2WFVnFK0PiI__OWu9jWxbqz5eMqeTDc4xZhOzPlgoEqGh5PmxOqlf8ZY.js"></script>
<script type="text/javascript" async="async" src="https://scholar.google.com/scholar_js/casa.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
/*!
 * yepnope1.5.4
 * (c) WTFPL, GPLv2
 */
(function(a,b,c){function d(a){return"[object Function]"==o.call(a)}function e(a){return"string"==typeof a}function f(){}function g(a){return!a||"loaded"==a||"complete"==a||"uninitialized"==a}function h(){var a=p.shift();q=1,a?a.t?m(function(){("c"==a.t?B.injectCss:B.injectJs)(a.s,0,a.a,a.x,a.e,1)},0):(a(),h()):q=0}function i(a,c,d,e,f,i,j){function k(b){if(!o&&g(l.readyState)&&(u.r=o=1,!q&&h(),l.onload=l.onreadystatechange=null,b)){"img"!=a&&m(function(){t.removeChild(l)},50);for(var d in y[c])y[c].hasOwnProperty(d)&&y[c][d].onload()}}var j=j||B.errorTimeout,l=b.createElement(a),o=0,r=0,u={t:d,s:c,e:f,a:i,x:j};1===y[c]&&(r=1,y[c]=[]),"object"==a?l.data=c:(l.src=c,l.type=a),l.width=l.height="0",l.onerror=l.onload=l.onreadystatechange=function(){k.call(this,r)},p.splice(e,0,u),"img"!=a&&(r||2===y[c]?(t.insertBefore(l,s?null:n),m(k,j)):y[c].push(l))}function j(a,b,c,d,f){return q=0,b=b||"j",e(a)?i("c"==b?v:u,a,b,this.i++,c,d,f):(p.splice(this.i++,0,a),1==p.length&&h()),this}function k(){var a=B;return a.loader={load:j,i:0},a}var l=b.documentElement,m=a.setTimeout,n=b.getElementsByTagName("script")[0],o={}.toString,p=[],q=0,r="MozAppearance"in l.style,s=r&&!!b.createRange().compareNode,t=s?l:n.parentNode,l=a.opera&&"[object Opera]"==o.call(a.opera),l=!!b.attachEvent&&!l,u=r?"object":l?"script":"img",v=l?"script":u,w=Array.isArray||function(a){return"[object Array]"==o.call(a)},x=[],y={},z={timeout:function(a,b){return b.length&&(a.timeout=b[0]),a}},A,B;B=function(a){function b(a){var a=a.split("!"),b=x.length,c=a.pop(),d=a.length,c={url:c,origUrl:c,prefixes:a},e,f,g;for(f=0;f<d;f++)g=a[f].split("="),(e=z[g.shift()])&&(c=e(c,g));for(f=0;f<b;f++)c=x[f](c);return c}function g(a,e,f,g,h){var i=b(a),j=i.autoCallback;i.url.split(".").pop().split("?").shift(),i.bypass||(e&&(e=d(e)?e:e[a]||e[g]||e[a.split("/").pop().split("?")[0]]),i.instead?i.instead(a,e,f,g,h):(y[i.url]?i.noexec=!0:y[i.url]=1,f.load(i.url,i.forceCSS||!i.forceJS&&"css"==i.url.split(".").pop().split("?").shift()?"c":c,i.noexec,i.attrs,i.timeout),(d(e)||d(j))&&f.load(function(){k(),e&&e(i.origUrl,h,g),j&&j(i.origUrl,h,g),y[i.url]=2})))}function h(a,b){function c(a,c){if(a){if(e(a))c||(j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}),g(a,j,b,0,h);else if(Object(a)===a)for(n in m=function(){var b=0,c;for(c in a)a.hasOwnProperty(c)&&b++;return b}(),a)a.hasOwnProperty(n)&&(!c&&!--m&&(d(j)?j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}:j[n]=function(a){return function(){var b=[].slice.call(arguments);a&&a.apply(this,b),l()}}(k[n])),g(a[n],j,b,n,h))}else!c&&l()}var h=!!a.test,i=a.load||a.both,j=a.callback||f,k=j,l=a.complete||f,m,n;c(h?a.yep:a.nope,!!i),i&&c(i)}var i,j,l=this.yepnope.loader;if(e(a))g(a,0,l,0);else if(w(a))for(i=0;i<a.length;i++)j=a[i],e(j)?g(j,0,l,0):w(j)?B(j):Object(j)===j&&h(j,l);else Object(a)===a&&h(a,l)},B.addPrefix=function(a,b){z[a]=b},B.addFilter=function(a){x.push(a)},B.errorTimeout=1e4,null==b.readyState&&b.addEventListener&&(b.readyState="loading",b.addEventListener("DOMContentLoaded",A=function(){b.removeEventListener("DOMContentLoaded",A,0),b.readyState="complete"},0)),a.yepnope=k(),a.yepnope.executeStack=h,a.yepnope.injectJs=function(a,c,d,e,i,j){var k=b.createElement("script"),l,o,e=e||B.errorTimeout;k.src=a;for(o in d)k.setAttribute(o,d[o]);c=j?h:c||f,k.onreadystatechange=k.onload=function(){!l&&g(k.readyState)&&(l=1,c(),k.onload=k.onreadystatechange=null)},m(function(){l||(l=1,c(1))},e),i?k.onload():n.parentNode.insertBefore(k,n)},a.yepnope.injectCss=function(a,c,d,e,g,i){var e=b.createElement("link"),j,c=i?h:c||f;e.href=a,e.rel="stylesheet",e.type="text/css";for(j in d)e.setAttribute(j,d[j]);g||(n.parentNode.insertBefore(e,n),m(c,0))}})(this,document);

//--><!]]>
</script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
yepnope({
  test: Modernizr.matchmedia,
  nope: '/sites/all/libraries/media-match/media.match.min.js'
});
//--><!]]>
</script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
var _prum=[['id', '52e95df3abe53d2e33000000'], ['mark', 'firstbyte',
      (new Date()).getTime()]]; (function() {
      var s=document.getElementsByTagName('script')[0],
      p=document.createElement('script');
      p.async='async'; p.src='//rum-static.pingdom.net/prum.min.js';s.parentNode.insertBefore(p,s);})();
//--><!]]>
</script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
if(typeof window.MathJax === "undefined") window.MathJax = { menuSettings: { zoom: "Click" } };
//--><!]]>
</script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
(function(i,s,o,g,r,a,m){i["GoogleAnalyticsObject"]=r;i[r]=i[r]||function(){(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)})(window,document,"script","//www.google-analytics.com/analytics.js","ga");ga("create", "UA-141606356-1", {"cookieDomain":"auto"});ga("set", "page", location.pathname + location.search + location.hash);ga("send", "pageview");ga('create', 'UA-189672-38', 'auto', {'name': 'hwTracker'});
ga('set', 'anonymizeIp', true);
ga('hwTracker.send', 'pageview');
//--><!]]>
</script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
jQuery.extend(Drupal.settings,{"basePath":"\/","pathPrefix":"","ajaxPageState":{"theme":"jcore_1","theme_token":"6YvfOl9yoHebg50FBa-QS3gdRDk-BY9jX4oE69Wj67M"},"colorbox":{"opacity":"0.85","current":"{current} of {total}","previous":"\u00ab Prev","next":"Next \u00bb","close":"Close","maxWidth":"98%","maxHeight":"98%","fixed":true,"mobiledetect":true,"mobiledevicewidth":"480px"},"highwire":{"nid":"426620","apath":"\/medrxiv\/early\/2021\/10\/26\/2021.10.25.21265462.atom","pisa":"medrxiv;2021.10.25.21265462v1","ac":{"\/medrxiv\/early\/2021\/10\/26\/2021.10.25.21265462.atom":{"access":{"full":true},"pisa_id":"","apath":"\/medrxiv\/early\/2021\/10\/26\/2021.10.25.21265462.atom","jcode":"medrxiv"}},"processed":["highwire_math"],"markup":[{"requested":"abstract","variant":"abstract","view":"abstract","pisa":"medrxiv;2021.10.25.21265462v1"}],"modal_window_width":"560","share_modal_width":"560","share_modal_title":"Share this Article"},"jcarousel":{"ajaxPath":"\/jcarousel\/ajax\/views"},"instances":"{\u0022highwire_abstract_tooltip\u0022:{\u0022content\u0022:{\u0022text\u0022:\u0022\u0022},\u0022style\u0022:{\u0022tip\u0022:{\u0022width\u0022:20,\u0022height\u0022:20,\u0022border\u0022:1,\u0022offset\u0022:0,\u0022corner\u0022:true},\u0022classes\u0022:\u0022qtip-custom hw-tooltip hw-abstract-tooltip qtip-shadow qtip-rounded\u0022,\u0022classes_custom\u0022:\u0022hw-tooltip hw-abstract-tooltip\u0022},\u0022position\u0022:{\u0022at\u0022:\u0022right center\u0022,\u0022my\u0022:\u0022left center\u0022,\u0022viewport\u0022:true,\u0022adjust\u0022:{\u0022method\u0022:\u0022shift\u0022}},\u0022show\u0022:{\u0022event\u0022:\u0022mouseenter click \u0022,\u0022solo\u0022:true},\u0022hide\u0022:{\u0022event\u0022:\u0022mouseleave \u0022,\u0022fixed\u0022:1,\u0022delay\u0022:\u0022100\u0022}},\u0022highwire_author_tooltip\u0022:{\u0022content\u0022:{\u0022text\u0022:\u0022\u0022},\u0022style\u0022:{\u0022tip\u0022:{\u0022width\u0022:15,\u0022height\u0022:15,\u0022border\u0022:1,\u0022offset\u0022:0,\u0022corner\u0022:true},\u0022classes\u0022:\u0022qtip-custom hw-tooltip hw-author-tooltip qtip-shadow qtip-rounded\u0022,\u0022classes_custom\u0022:\u0022hw-tooltip hw-author-tooltip\u0022},\u0022position\u0022:{\u0022at\u0022:\u0022top center\u0022,\u0022my\u0022:\u0022bottom center\u0022,\u0022viewport\u0022:true,\u0022adjust\u0022:{\u0022method\u0022:\u0022\u0022}},\u0022show\u0022:{\u0022event\u0022:\u0022mouseenter \u0022,\u0022solo\u0022:true},\u0022hide\u0022:{\u0022event\u0022:\u0022mouseleave \u0022,\u0022fixed\u0022:1,\u0022delay\u0022:\u0022100\u0022}},\u0022highwire_reflinks_tooltip\u0022:{\u0022content\u0022:{\u0022text\u0022:\u0022\u0022},\u0022style\u0022:{\u0022tip\u0022:{\u0022width\u0022:15,\u0022height\u0022:15,\u0022border\u0022:1,\u0022mimic\u0022:\u0022top center\u0022,\u0022offset\u0022:0,\u0022corner\u0022:true},\u0022classes\u0022:\u0022qtip-custom hw-tooltip hw-ref-link-tooltip qtip-shadow qtip-rounded\u0022,\u0022classes_custom\u0022:\u0022hw-tooltip hw-ref-link-tooltip\u0022},\u0022position\u0022:{\u0022at\u0022:\u0022bottom left\u0022,\u0022my\u0022:\u0022top left\u0022,\u0022viewport\u0022:true,\u0022adjust\u0022:{\u0022method\u0022:\u0022flip\u0022}},\u0022show\u0022:{\u0022event\u0022:\u0022mouseenter \u0022,\u0022solo\u0022:true},\u0022hide\u0022:{\u0022event\u0022:\u0022mouseleave \u0022,\u0022fixed\u0022:1,\u0022delay\u0022:\u0022100\u0022}}}","qtipDebug":"{\u0022leaveElement\u0022:0}","panel_ajax_tab":{"path":"sites\/all\/modules\/contrib\/panels_ajax_tab"},"disqus":{"domain":"medRxiv","url":"https:\/\/www.medrxiv.org\/content\/10.1101\/2021.10.25.21265462v1","title":"REcovery and SURvival of patients with moderate to severe acute REspiratory distress syndrome (ARDS) due to COVID-19: a multicentre, single-arm, Phase IV Itolizumab Trial: RESURRECT","identifier":"node\/426620"},"panels_ajax_pane":{"new-41":"{\u0022encrypted\u0022:\u0022{\\\u0022encrypted\\\u0022:\\\u0022FLj1QykRNNVPe8\\\\\\\/asFqLfs\\\\\\\/s8BkMARP8DQFlIQEeRpCVUn2ADn+Obzo3QrS5WjbQJEaHc752Z5OyL3GLWZSbG2xAbG1sM+xNyI9Cowt3tfYOaATS5yYz\\\\\\\/M6EV59fLnMd7LxFybzyhit4VntBbPmiPz+8nAgHWyMofj+Dqoa8w5e7RkX8CwdcbvTYIhjmLecHWOcC1UUc1O6k7mcXNCQkDUESFyFokquhMedn+4H5nkiiZi7kb54oD5q+MI\\\\\\\/B045NH3YnRxoxZd1jcCIkolXn0QQ67VMRT7tQqzLiSxxiJ4KEhnK4yNwDVEDo6hFjipfBw7ZEG0qQajxZ8FYZrpDyxpDEFzYKoiy7g41Udf8yAUqiUgXAIaDTprN4eP0i75XH0Ag40H1RVNCr8VqXEovuqyBP57Lnd+vRePMbwGtpzSfAG1xcdKVccuOWvJSp6nAQWPWxZpo4qW0nJue2Lgt\\\\\\\/78h6fHmZAR\\\\\\\/sylNHwH8UPS2y2UCFvwjCSOZfTh9aEFgziPiH8aFcFXkZBA4vNB7benfGEt0CZlKvsxPncqMD+UxhSGeMDv7\\\\\\\/by0Nt\\\\\\\/CmNxkwBfREvvJOFRpClS9ntATcJdgQRruepXukx5wrvHXBfxA4ctZnPlAghf9V8erC7sdofS8iM49jZQRwSOkI2KBkXlAYQ+hgqCxgcmgnupZBzbln8DrbOTuImlW1JIsx4A8FJ7TfjovPtMsVgwJAv7k2\\\\\\\/J5hxihZI+oNYtzUVEC+\\\\\\\/FOwj5SJ\\\\\\\/Ht2nf1dDTGTp4q9rnpaXvEbhvPDYrZb5NciGurlaI4T\\\\\\\/ng7AU3CbvF1tRm6l2Et0ipAQf0bGMzXd5gLnk1KyOhnH2gRnK\\\\\\\/49skjFsd2EpUr3SRZn96JyuHD+hKidhGbBtDMCibidwyAlaJ0iamwRcBwMEApOo5ZFzzFdsGBFGlk0W3sH57HZ2P\\\\\\\/RF024w02ZLhBKE8wJUnncXt7Jmva7UKt3oymJ7RR\\\\\\\/5ws6dc4AYq04ODz3q8\\\\\\\/8yMET9utGN+xPSkuEKbsFCR6MYyk5z581DO1oZQbvXdV0VV8ffRci3ZyvIziaTRJKouraGuQKVloF2DsKbaz0fBcIrFILCG9vv52WNhClsSXr+l2SbVYdIFJNtE9WljYBEquj0tZSsLA7+6W0a\\\\\\\/8oaDbRyx07bsavFVWRsg7XSo1ibMrHRjX07P5Yh8bXymwC8OEK2I6amQjb0FMCQXpskQGZ5L\\\\\\\/9HYbYO51mr8O3pkNKrlHfpqH5VTJPK6rErxEcurb3J16fT4XIR3bWCHGE3gPtZAg\\\u0022,\\\u0022iv\\\u0022:\\\u0022PUTvfN1HUZKxtf33ImCblw==\\\u0022,\\\u0022salt\\\u0022:\\\u0022f9d8845712f72c9fee5db7d9ff111eab\\\u0022}\u0022,\u0022hmac\u0022:\u0022a877b4882705b2d056f128304b00ef5c300c8893dd24e183916813aea43cc8da\u0022}"},"urlIsAjaxTrusted":{"\/content\/10.1101\/2021.10.25.21265462v1":true},"ws_fl":{"width":100,"height":21},"ws_gpo":{"size":"","annotation":"","lang":"","callback":"","width":300},"color":{"logo":"https:\/\/www.medrxiv.org\/sites\/default\/files\/medrxiv_internal_logo.png"},"highwire_list_expand":{"is_collapsed":"1"},"highwireResponsive":{"enquire_enabled":1,"breakpoints_configured":1,"breakpoints":{"zero":"all and (min-width: 0px)","xsmall":"all and (min-width: 380px)","narrow":"all and (min-width: 768px) and (min-device-width: 768px), (max-device-width: 800px) and (min-width: 768px) and (orientation:landscape)","normal":"all and (min-width: 980px) and (min-device-width: 980px), all and (max-device-width: 1024px) and (min-width: 1024px) and (orientation:landscape)","wide":"all and (min-width: 1220px)"}},"eu_cookie_compliance":{"popup_enabled":1,"popup_agreed_enabled":0,"popup_hide_agreed":0,"popup_clicking_confirmation":1,"popup_scrolling_confirmation":false,"popup_html_info":"\u003Cdiv\u003E\n  \u003Cdiv class =\u0022popup-content info\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n      \u003Cp\u003EWe use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.\u003C\/p\u003E\n    \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022agree-button eu-cookie-compliance-default-button\u0022\u003EContinue\u003C\/button\u003E\n                    \u003Cbutton type=\u0022button\u0022 class=\u0022find-more-button eu-cookie-compliance-more-button\u0022\u003EFind out more\u003C\/button\u003E\n          \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E","use_mobile_message":false,"mobile_popup_html_info":"\u003Cdiv\u003E\n  \u003Cdiv class =\u0022popup-content info\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n          \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022agree-button eu-cookie-compliance-default-button\u0022\u003EContinue\u003C\/button\u003E\n                    \u003Cbutton type=\u0022button\u0022 class=\u0022find-more-button eu-cookie-compliance-more-button\u0022\u003EFind out more\u003C\/button\u003E\n          \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E\n","mobile_breakpoint":"768","popup_html_agreed":"\u003Cdiv\u003E\n  \u003Cdiv class=\u0022popup-content agreed\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n      \u003Ch2\u003EThank you for accepting cookies\u003C\/h2\u003E\u003Cp\u003EYou can now hide this message or find out more about cookies.\u003C\/p\u003E    \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022hide-popup-button eu-cookie-compliance-hide-button\u0022\u003EHide\u003C\/button\u003E\n              \u003Cbutton type=\u0022button\u0022 class=\u0022find-more-button eu-cookie-compliance-more-button-thank-you\u0022 \u003EMore info\u003C\/button\u003E\n          \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E","popup_use_bare_css":false,"popup_height":"auto","popup_width":"100%","popup_delay":1000,"popup_link":"\/help\/cookie-policy","popup_link_new_window":1,"popup_position":null,"popup_language":"en","store_consent":false,"better_support_for_screen_readers":0,"reload_page":0,"domain":"","popup_eu_only_js":0,"cookie_lifetime":"365","cookie_session":false,"disagree_do_not_show_popup":0,"method":"default","whitelisted_cookies":"","withdraw_markup":"\u003Cbutton type=\u0022button\u0022 class=\u0022eu-cookie-withdraw-tab\u0022\u003EPrivacy settings\u003C\/button\u003E\n\u003Cdiv class=\u0022eu-cookie-withdraw-banner\u0022\u003E\n  \u003Cdiv class=\u0022popup-content info\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n      \u003Cp\u003E\u0026lt;h2\u0026gt;We use cookies on this site to enhance your user experience\u0026lt;\/h2\u0026gt;\u0026lt;p\u0026gt;You have given your consent for us to set cookies.\u0026lt;\/p\u0026gt;\u003C\/p\u003E\n    \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022eu-cookie-withdraw-button\u0022\u003EWithdraw consent\u003C\/button\u003E\n    \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E\n","withdraw_enabled":false},"googleanalytics":{"trackOutbound":1,"trackMailto":1,"trackDownload":1,"trackDownloadExtensions":"7z|aac|arc|arj|asf|asx|avi|bin|csv|doc(x|m)?|dot(x|m)?|exe|flv|gif|gz|gzip|hqx|jar|jpe?g|js|mp(2|3|4|e?g)|mov(ie)?|msi|msp|pdf|phps|png|ppt(x|m)?|pot(x|m)?|pps(x|m)?|ppam|sld(x|m)?|thmx|qtm?|ra(m|r)?|sea|sit|tar|tgz|torrent|txt|wav|wma|wmv|wpd|xls(x|m|b)?|xlt(x|m)|xlam|xml|z|zip","trackColorbox":1,"trackUrlFragments":1},"jnl_biorxiv_styles":{"defaultJCode":"medrxiv"},"omega":{"layouts":{"primary":"normal","order":["narrow","normal","wide"],"queries":{"narrow":"all and (min-width: 768px) and (min-device-width: 768px), (max-device-width: 800px) and (min-width: 768px) and (orientation:landscape)","normal":"all and (min-width: 980px) and (min-device-width: 980px), all and (max-device-width: 1024px) and (min-width: 1024px) and (orientation:landscape)","wide":"all and (min-width: 1220px)"}}}});
//--><!]]>
</script>
    <!--[if lt IE 9]><script src="http://html5shiv.googlecode.com/svn/trunk/html5.js"></script><![endif]-->
  </head>
  <body class="html not-front not-logged-in page-node page-node- page-node-426620 node-type-highwire-article context-content hw-default-jcode-medrxiv hw-article-type-article">
<!-- Google Tag Manager -->
<noscript><iframe src="//www.googletagmanager.com/ns.html?id=GTM-P4HH5NV" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
<script type="text/javascript">(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0];var j=d.createElement(s);var dl=l!='dataLayer'?'&l='+l:'';j.src='//www.googletagmanager.com/gtm.js?id='+i+dl;j.type='text/javascript';j.async=true;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-P4HH5NV');</script>
<!-- End Google Tag Manager -->
    <div id="skip-link">
      <a href="#main-content" class="element-invisible element-focusable">Skip to main content</a>
    </div>
        <div class="page clearfix page-box-shadows footer-borders panels-page panels-layout-jcore_2col" id="page">
      <header id="section-header" class="section section-header">
    
  <div id="zone-branding" class="zone zone-branding clearfix print-display-block container-30">
    <div class="grid-15 prefix-1 region region-branding print-display-block" id="region-branding">
  <div class="region-inner region-branding-inner">
        <div class="branding-data clearfix">
            <div class="logo-img">
        <a href="/" rel="home" class="" data-icon-position="" data-hide-link-title="0"><img alt="medRxiv" src="https://www.medrxiv.org/sites/default/files/medrxiv_internal_logo.png" /></a>      </div>
                </div>
          </div>
</div><div class="grid-11 suffix-1 region region-branding-second print-hidden" id="region-branding-second">
  <div class="region-inner region-branding-second-inner">
    <div class="block block-system block-menu block-main-menu block-system-main-menu odd block-without-title" id="block-system-main-menu">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <nav class="menubar-nav"><ul class="menu" role="menu"><li class="first leaf" role="menuitem"><a href="/" title="" class="" data-icon-position="" data-hide-link-title="0">Home</a></li>
<li class="leaf" role="menuitem"><a href="/content/about-medrxiv" class="" data-icon-position="" data-hide-link-title="0">About</a></li>
<li class="leaf" role="menuitem"><a href="/submit-a-manuscript" class="" data-icon-position="" data-hide-link-title="0">Submit</a></li>
<li class="last leaf" role="menuitem"><a href="/content/alertsrss" title="" class="" data-icon-position="" data-hide-link-title="0">ALERTS / RSS</a></li>
</ul></nav>    </div>
  </div>
</div><div class="block block-panels-mini block-biorxiv-search-box block-panels-mini-biorxiv-search-box even block-without-title" id="block-panels-mini-biorxiv-search-box">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <div class="panel-display panel-1col clearfix" id="mini-panel-biorxiv_search_box">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-highwire-seach-quicksearch" >
  
      
  
  <div class="pane-content">
    <form class="highwire-quicksearch button-style-mini button-style-mini" action="/content/10.1101/2021.10.25.21265462v1" method="post" id="highwire-search-quicksearch-form-0" accept-charset="UTF-8"><div><div class="form-item form-item-label-invisible form-type-textfield form-item-keywords">
  <label class="element-invisible" for="edit-keywords">Search for this keyword </label>
 <input placeholder="Search" type="text" id="edit-keywords" name="keywords" value="" size="60" maxlength="128" class="form-text" />
</div>
<div class="button-wrapper button-mini"><span class="icon-search"></span><input data-icon-only="1" data-font-icon="icon-search" data-icon-position="after" type="submit" id="edit-submit--2" name="op" value="Search" class="form-submit" /></div><input type="hidden" name="form_build_id" value="form-IpUbERhgGJpjCk2VT16Miflr96H8LWfcDPQQPdrYQSU" />
<input type="hidden" name="form_id" value="highwire_search_quicksearch_form_0" />
</div></form>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-custom pane-2 advanced-search-link" >
  
      
  
  <div class="pane-content">
    <a href="/search">Advanced Search</a>  </div>

  
  </div>
</div>
  </div>
</div>
    </div>
  </div>
</div>  </div>
</div>  </div>
  
  <div id="zone-header" class="zone zone-header clearfix container-30">
  	      </div>
</header>    
      <section id="section-content" class="section section-content">
    
  <div id="zone-content" class="zone zone-content clearfix container-30">    
        
    <div class="grid-28 suffix-1 prefix-1 region region-content" id="region-content">
  <div class="region-inner region-content-inner">
    <a id="main-content"></a>
                        <div class="block block-system block-main block-system-main odd block-without-title" id="block-system-main">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <div class="panel-display panels-960-layout jcore-2col-layout" >
	  
  <div class="panel-row-wrapper clearfix">
		
		<div class="main-content-wrapper grid-17 suffix-1 alpha">
			<div class="panel-panel panel-region-content">
			  <div class="inside"><div class="panel-pane pane-highwire-article-citation" >
  
      
  
  <div class="pane-content">
    <div class="highwire-article-citation highwire-citation-type-highwire-article node426620" data-node-nid="426620" id="node426620--21178348201" data-pisa="medrxiv;2021.10.25.21265462v1" data-pisa-master="medrxiv;2021.10.25.21265462" data-apath="/medrxiv/early/2021/10/26/2021.10.25.21265462.atom" data-hw-author-tooltip-instance=""><div  class="highwire-cite highwire-cite-highwire-article highwire-citation-medrxiv-article-top clearfix has-author-tooltip" >

  
      <h1 class="highwire-cite-title" id="page-title"><strong>RE</strong>covery and <strong>SUR</strong>vival of patients with moderate to severe acute <strong>RE</strong>spiratory distress syndrome (ARDS) due to <strong>C</strong>OVID-19: a multicentre, single-arm, Phase IV Itolizumab <strong>T</strong>rial: <strong>RESURRECT</strong></h1>  
      <div  class="highwire-cite-authors" ><span  class="highwire-citation-authors"><span class="highwire-citation-author first" data-delta="0"><span class="nlm-given-names">KR</span> <span class="nlm-surname">Raveendra</span></span>, <span class="highwire-citation-author" data-delta="1"><span class="nlm-given-names">Chirag</span> <span class="nlm-surname">Rathod</span></span>, <span class="highwire-citation-author" data-delta="2"><span class="nlm-given-names">Rahul</span> <span class="nlm-surname">Darnule</span></span>, <span class="highwire-citation-author hw-author-orcid-logo-wrapper" data-delta="3"><a href="http://orcid.org/0000-0001-7186-0049" target="_blank" class="hw-author-orcid-logo link-icon-only link-icon"><span class="hw-icon-orcid hw-icon-color-orcid"></span> <span class="title element-invisible">View ORCID Profile</span></a><span class="nlm-given-names">Subramanian</span> <span class="nlm-surname">Loganathan</span></span>, <span class="highwire-citation-author" data-delta="4"><span class="nlm-given-names">Sarika</span> <span class="nlm-surname">Deodhar</span></span>, <span class="highwire-citation-author" data-delta="5"><span class="nlm-given-names">A</span> <span class="nlm-surname">Radhika</span></span>, <span class="highwire-citation-author" data-delta="6"><span class="nlm-given-names">Ashwani</span> <span class="nlm-surname">Marwah</span></span>, <span class="highwire-citation-author" data-delta="7"><span class="nlm-given-names">Nitin M</span> <span class="nlm-surname">Chaudhari</span></span>, <span class="highwire-citation-author" data-delta="8"><span class="nlm-given-names">Binay K</span> <span class="nlm-surname">Thakur</span></span>, <span class="highwire-citation-author" data-delta="9"><span class="nlm-given-names">Sivakumar</span> <span class="nlm-surname">Vaidyanathan</span></span>, <span class="highwire-citation-author" data-delta="10"><span class="nlm-given-names">Sandeep Nilkanth</span> <span class="nlm-surname">Athalye</span></span></span></div>
  
      <div  class="highwire-cite-metadata" ><span  class="highwire-cite-metadata-doi highwire-cite-metadata"><span class="label">doi:</span> https://doi.org/10.1101/2021.10.25.21265462 </span></div>
  
  
  
</div>
<div id="hw-article-author-popups-node426620--21178348201" style="display: none;"><div class="author-tooltip-0"><div class="author-tooltip-name">KR Raveendra </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>1</span><span class='nlm-institution'>Victoria Hospital, Bangalore Medical College and Research Institute</span>, Bangalore, Karnataka, <span class='nlm-country'>India</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=KR%2BRaveendra%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Raveendra%20K&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AKR%2BRaveendra%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-1"><div class="author-tooltip-name">Chirag Rathod </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>2</span><span class='nlm-institution'>GMERS Medical College & Hospital</span>, Old TB Hospital Campus, Vadodara, Gujarat, <span class='nlm-country'>India</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Chirag%2BRathod%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Rathod%20C&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AChirag%2BRathod%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-2"><div class="author-tooltip-name">Rahul Darnule </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>3</span><span class='nlm-institution'>Saint George’s Hospital</span>, Mumbai, Maharashtra, <span class='nlm-country'>India</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Rahul%2BDarnule%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Darnule%20R&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3ARahul%2BDarnule%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-3"><div class="author-tooltip-name">Subramanian Loganathan </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>4</span><span class='nlm-institution'>Clinical Development and Medical Affairs</span>, Biocon Biologics Ltd, Bengaluru, Karnataka, <span class='nlm-country'>India</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Subramanian%2BLoganathan%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Loganathan%20S&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link"><a href="/search/author1%3ASubramanian%2BLoganathan%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li><li class="author-orcid-link"><a href="http://orcid.org/0000-0001-7186-0049" target="_blank" class="" data-icon-position="" data-hide-link-title="0">ORCID record for Subramanian Loganathan</a></li><li class="author-corresp-email-link last"><span>For correspondence: 
<a href="mailto:subramanian.l101@biocon.com" class="" data-icon-position="" data-hide-link-title="0">subramanian.l101@biocon.com</a></span></li></ul></div><div class="author-tooltip-4"><div class="author-tooltip-name">Sarika Deodhar </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>4</span><span class='nlm-institution'>Clinical Development and Medical Affairs</span>, Biocon Biologics Ltd, Bengaluru, Karnataka, <span class='nlm-country'>India</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Sarika%2BDeodhar%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Deodhar%20S&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3ASarika%2BDeodhar%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-5"><div class="author-tooltip-name">A Radhika </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>4</span><span class='nlm-institution'>Clinical Development and Medical Affairs</span>, Biocon Biologics Ltd, Bengaluru, Karnataka, <span class='nlm-country'>India</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=A%2BRadhika%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Radhika%20A&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AA%2BRadhika%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-6"><div class="author-tooltip-name">Ashwani Marwah </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>4</span><span class='nlm-institution'>Clinical Development and Medical Affairs</span>, Biocon Biologics Ltd, Bengaluru, Karnataka, <span class='nlm-country'>India</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Ashwani%2BMarwah%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Marwah%20A&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AAshwani%2BMarwah%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-7"><div class="author-tooltip-name">Nitin M Chaudhari </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>4</span><span class='nlm-institution'>Clinical Development and Medical Affairs</span>, Biocon Biologics Ltd, Bengaluru, Karnataka, <span class='nlm-country'>India</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Nitin%2BM%2BChaudhari%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Chaudhari%20NM&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3ANitin%2BM%2BChaudhari%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-8"><div class="author-tooltip-name">Binay K Thakur </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>4</span><span class='nlm-institution'>Clinical Development and Medical Affairs</span>, Biocon Biologics Ltd, Bengaluru, Karnataka, <span class='nlm-country'>India</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Binay%2BK%2BThakur%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Thakur%20BK&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3ABinay%2BK%2BThakur%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-9"><div class="author-tooltip-name">Sivakumar Vaidyanathan </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>4</span><span class='nlm-institution'>Clinical Development and Medical Affairs</span>, Biocon Biologics Ltd, Bengaluru, Karnataka, <span class='nlm-country'>India</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Sivakumar%2BVaidyanathan%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Vaidyanathan%20S&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3ASivakumar%2BVaidyanathan%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-10"><div class="author-tooltip-name">Sandeep Nilkanth Athalye </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>4</span><span class='nlm-institution'>Clinical Development and Medical Affairs</span>, Biocon Biologics Ltd, Bengaluru, Karnataka, <span class='nlm-country'>India</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Sandeep%2BNilkanth%2BAthalye%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Athalye%20SN&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3ASandeep%2BNilkanth%2BAthalye%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div></div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-panel-tabs pane-panels-ajax-tab-tabs" >
  
      
  
  <div class="pane-content">
    <div class="item-list"><ul class="tabs inline panels-ajax-tab"><li class="first"><a href="/content/10.1101/2021.10.25.21265462v1" class="panels-ajax-tab-tab" data-panel-name="biorxiv_tab_art" data-target-id="highwire_article_tabs" data-entity-context="node:426620" data-trigger="" data-url-enabled="1">Abstract</a><a href="/panels_ajax_tab/biorxiv_tab_art/node:426620/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li><a href="/content/10.1101/2021.10.25.21265462v1.full-text" class="panels-ajax-tab-tab" data-panel-name="article_tab_full_text" data-target-id="highwire_article_tabs" data-entity-context="node:426620" data-trigger="full-text" data-url-enabled="1">Full Text</a><a href="/panels_ajax_tab/article_tab_full_text/node:426620/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li><a href="/content/10.1101/2021.10.25.21265462v1.article-info" class="panels-ajax-tab-tab" data-panel-name="biorxiv_tab_info" data-target-id="highwire_article_tabs" data-entity-context="node:426620" data-trigger="article-info" data-url-enabled="1">Info/History</a><a href="/panels_ajax_tab/biorxiv_tab_info/node:426620/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li><a href="/content/10.1101/2021.10.25.21265462v1.article-metrics" class="panels-ajax-tab-tab" data-panel-name="article_tab_metrics" data-target-id="highwire_article_tabs" data-entity-context="node:426620" data-trigger="article-metrics" data-url-enabled="1">Metrics</a><a href="/panels_ajax_tab/article_tab_metrics/node:426620/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li><a href="/content/10.1101/2021.10.25.21265462v1.supplementary-material" class="panels-ajax-tab-tab" data-panel-name="biorxiv_tab_data" data-target-id="highwire_article_tabs" data-entity-context="node:426620" data-trigger="supplementary-material" data-url-enabled="1">Supplementary material</a><a href="/panels_ajax_tab/biorxiv_tab_data/node:426620/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li><a href="/content/10.1101/2021.10.25.21265462v1.external-links" class="panels-ajax-tab-tab" data-panel-name="article_tab_data_code" data-target-id="highwire_article_tabs" data-entity-context="node:426620" data-trigger="external-links" data-url-enabled="1">Data/Code</a><a href="/panels_ajax_tab/article_tab_data_code/node:426620/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li class="last"><a href="/content/10.1101/2021.10.25.21265462v1.full.pdf+html" class="panels-ajax-tab-tab" data-panel-name="biorxiv_tab_pdf" data-target-id="highwire_article_tabs" data-entity-context="node:426620" data-trigger="full.pdf+html" data-url-enabled="1"><i class="icon-file-alt"></i> Preview PDF</a><a href="/panels_ajax_tab/biorxiv_tab_pdf/node:426620/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li></ul></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-panel-tabs-container" >
  
      
  
  <div class="pane-content">
    <div data-panels-ajax-tab-preloaded="biorxiv_tab_art" id="panels-ajax-tab-container-highwire_article_tabs" class="panels-ajax-tab-container"><div class="panels-ajax-tab-loading" style ="display:none"><img class="loading" src="https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif" alt="Loading" title="Loading" /></div><div class="panels-ajax-tab-wrap-biorxiv_tab_art"><div class="panel-display panel-1col clearfix" >
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-highwire-markup" >
  
      
  
  <div class="pane-content">
    <div class="highwire-markup"><div xmlns="http://www.w3.org/1999/xhtml" data-highwire-cite-ref-tooltip-instance="highwire_reflinks_tooltip" class="content-block-markup" xmlns:xhtml="http://www.w3.org/1999/xhtml"><div class="article abstract-view "><span class="highwire-journal-article-marker-start"></span><div class="section abstract" id="abstract-1"><h2 class="">Abstract</h2><div id="sec-1" class="subsection"><p id="p-2"><strong>Objective</strong> To evaluate safety and efficacy of Itolizumab in hospitalized COVID-19 patients with PaO<sub>2</sub>/FiO<sub>2</sub> ratio (PFR) ≤200 requiring oxygen therapy.</p></div><div id="sec-2" class="subsection"><p id="p-3"><strong>Design</strong> A multicentre, single-arm, Phase-4 study with a treatment period of 30-Days and an extended follow-up period of 90-Days.</p></div><div id="sec-3" class="subsection"><p id="p-4"><strong>Methods</strong> Hospitalized adult patients (n=300) with SARS-CoV-2 infection, with PFR ≤200; oxygen saturation ≤94% and ≥1 elevated inflammatory markers were included from 17 COVID-19-specific tertiary hospitals in India. Patients received Itolizumab infusion 1.6 mg/kg and were assessed for 1-month and then followed up to Day-90.</p></div><div id="sec-4" class="subsection"><p id="p-5"><strong>Results</strong> Day-30 post-treatment safety/efficacy results and Day-90 mortality results are presented. Primary outcome measures: incidence of severe acute infusion-related reactions (IRRs) (≥Grade-3) was 1.3% and mortality rate at 1-month was 6.7% (n=20/300). Key secondary analyses: Mortality rate at Day-90 was 8.0% (24/300). 91.7% patients came off the oxygen therapy within Day-30 of treatment. By Day-7, most patients had stable/improved SpO<sub>2</sub> without increasing FiO<sub>2</sub>. Mean PFR improved by 50% by Day-7 (p&lt;0.001) and the trend remained consistent till Day-30. Median time of recovery was 8 days. Cumulatively, at Day-30, 260(86.7%), 256(85.3%), 132(44.0%), 113(37.6%) and 32(10.7%) patients showed &gt;1-point, &gt;2-point, &gt;3-point, &gt;4-point and 5-point improvement on the modified COVID-19 8-point ordinal scale and worsening of symptoms by &gt;1 point, &gt;2 points and 3-points was seen in 26(8.7%), 20(6.7%) and 6(2.0%) patients, respectively. CRP, D-dimer, LDH, and serum ferritin levels significantly decreased (p≤0.01) compared with baseline. IL-6 and TNFα levels also decreased 48-hours post-infusion. Overall, 123 treatment-emergent adverse events (TEAEs) were reported in 63 patients, most being Grades 1-3. Most common TEAEs were IRRs and lymphopenia; most common serious TEAEs were septic shock, worsening of ARDS, and respiratory failure. No deaths were attributable to Itolizumab.</p></div><div id="sec-5" class="subsection"><p id="p-6"><strong>Conclusion</strong> Itolizumab shows no new safety concerns and suggests a mortality and recovery benefit at 1-month in hospitalized COVID-19 patients requiring oxygen therapy.</p></div><div id="sec-6" class="subsection"><p id="p-7"><strong>Trial registry number</strong> CTRI/2020/09/027941</p></div></div><h3>Competing Interest Statement</h3><p id="p-8">Drs Raveendra KR, Chirag Rathod and Rahul Darnule received funding for the study and professional fees as Principal Investigators from Biocon Biologics Limited. All other authors are employees of Biocon Biologics Limited and may be eligible for stock and stock options.</p><h3>Clinical Trial</h3><p id="p-9">CTRI/2020/09/027941</p><h3>Funding Statement</h3><p id="p-10">This study was funded by Biocon Biologics Limited</p><h3>Author Declarations</h3><p id="p-11">I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.</p><p id="p-12">Yes</p><p id="p-13">The details of the IRB/oversight body that provided approval or exemption for the research described are given below:</p><p id="p-14">Institutional Ethics Committee of Govt. Medical College and Hospital, Nagpur gave ethical approval for this work
Institutional Ethics Committee of SRM Institutes for Medical Science, Chennai gave ethical approval for this work</p><p id="p-15">I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.</p><p id="p-16">Yes</p><p id="p-17">I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).</p><p id="p-18">Yes</p><p id="p-19">I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.</p><p id="p-20">Yes</p><div class="section data-availability" id="sec-34"><h2 class="">Data Availability</h2><p id="p-63">All data produced in the present study are available upon reasonable request to the authors</p></div><span class="highwire-journal-article-marker-end"></span></div><span class="related-urls"></span></div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-biorxiv-copyright" >
  
      
  
  <div class="pane-content">
    <div class="field field-name-field-highwire-copyright field-type-text field-label-inline clearfix"><div class="field-label">Copyright&nbsp;</div><div class="field-items"><div class="field-item even">The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.<span class="license-type-none"> All rights reserved. No reuse allowed without permission.</span></div></div></div>  </div>

  
  </div>
</div>
  </div>
</div>
</div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-disqus-comment" >
  
      
  
  <div class="pane-content">
    <div id="disqus_thread"><noscript><p><a href="http://medRxiv.disqus.com/?url=https%3A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.1101%2F2021.10.25.21265462v1" class="" data-icon-position="" data-hide-link-title="0">View the discussion thread.</a></p></noscript></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-back-to-top" >
  
      
  
  <div class="pane-content">
    <a href="#page" class="back-to-top" data-icon-position="" data-hide-link-title="0"><span class="icon-chevron-up"></span> Back to top</a>  </div>

  
  </div>
</div>
			</div>
		</div>
		
		<div class="sidebar-right-wrapper grid-10 omega">
			<div class="panel-panel panel-region-sidebar-right">
			  <div class="inside"><div class="panel-pane pane-highwire-node-pager" >
  
      
  
  <div class="pane-content">
    <div class="pager highwire-pager pager-mini clearfix highwire-node-pager highwire-article-pager"><span class="pager-prev"><a href="/content/10.1101/2021.10.19.21265154v1" title="Translational Modeling Identifies Synergy between Nanoparticle-Delivered miRNA-22 and Standard-of-Care Drugs in Triple Negative Breast Cancer" rel="prev" class="pager-link-prev link-icon"><span class="icon-circle-arrow-left"></span> <span class="title">Previous</span></a></span><span class="pager-next"><a href="/content/10.1101/2021.10.26.21265363v1" title="Network analysis of England’s single parent household COVID-19 control policy impact: a proof-of-concept study" rel="next" class="pager-link-next link-icon-right link-icon"><span class="title">Next</span> <span class="icon-circle-arrow-right"></span></a></span></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-custom pane-1" >
  
      
  
  <div class="pane-content">
    Posted&nbsp;October 26, 2021.  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-panels-mini pane-biorxiv-art-tools" >
  
      
  
  <div class="pane-content">
    <div id="mini-panel-biorxiv_art_tools" class="highwire-2col-stacked panel-display">
	  
  <div class="panel-row-wrapper clearfix">
		<div class="content-left-wrapper content-column">
          <div class="panel-panel panel-region-content-left">
            <div class="inside"><div class="panel-pane pane-highwire-variant-link" >
  
      
  
  <div class="pane-content">
    <a href="/content/10.1101/2021.10.25.21265462v1.full.pdf" target="_self" class="article-dl-pdf-link link-icon"><span class="icon-external-link-sign"></span> <span class="title">Download PDF</span></a>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-biorxiv-supplementary-fragment" >
  
      
  
  <div class="pane-content">
    <p><a href="/content/10.1101/2021.10.25.21265462v1.supplementary-material?versioned=true"><i class="icon-file"></i>Supplementary Material </a></p>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-variant-link" >
  
      
  
  <div class="pane-content">
    <a href="/content/early/2021/10/26/2021.10.25.21265462.external-links" target="_self" class="link-icon"><span class="icon-file"></span> <span class="title">Data/Code</span></a>  </div>

  
  </div>
</div>
          </div>
        </div>
        
        <div class="content-right-wrapper content-column">
          <div class="panel-panel panel-region-content-right">
            <div class="inside"><div class="panel-pane pane-minipanel-dialog-link pane-biorxiv-art-email" >
  
      
  
  <div class="pane-content">
    <div class='minipanel-dialog-wrapper'><div class='minipanel-dialog-link-link'><a href="/" oncontextmenu="javascript: return false;" class="minipanel-dialog-link-trigger" title="Email this Article" data-icon-position="" data-hide-link-title="0"><i class = 'icon-envelope'></i> Email</a></div><div class='minipanel-dialog-link-mini' style='display:none'><div class="panel-display panel-1col clearfix" id="mini-panel-biorxiv_art_email">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-block pane-forward-form pane-forward" >
  
      
  
  <div class="pane-content">
    <form action="/content/10.1101/2021.10.25.21265462v1" method="post" id="forward-form" accept-charset="UTF-8"><div><div id="edit-instructions" class="form-item form-item-label-before form-type-item">
 <p>Thank you for your interest in spreading the word about medRxiv.</p><p>NOTE: Your email address is requested solely to identify you as the sender of this article.</p>
</div>
<div class="form-item form-item-label-before form-type-textfield form-item-email">
  <label for="edit-email">Your Email <span class="form-required" title="This field is required.">*</span></label>
 <input type="text" id="edit-email" name="email" value="" size="58" maxlength="256" class="form-text required" />
</div>
<div class="form-item form-item-label-before form-type-textfield form-item-name">
  <label for="edit-name">Your Name <span class="form-required" title="This field is required.">*</span></label>
 <input type="text" id="edit-name" name="name" value="" size="58" maxlength="256" class="form-text required" />
</div>
<div class="form-item form-item-label-before form-type-textarea form-item-recipients">
  <label for="edit-recipients">Send To <span class="form-required" title="This field is required.">*</span></label>
 <div class="form-textarea-wrapper resizable"><textarea id="edit-recipients" name="recipients" cols="50" rows="5" class="form-textarea required"></textarea></div>
<div class="description">Enter multiple addresses on separate lines or separate them with commas.</div>
</div>
<div id="edit-page" class="form-item form-item-label-before form-type-item">
  <label for="edit-page">You are going to email the following </label>
 <a href="/content/10.1101/2021.10.25.21265462v1" class="active" data-icon-position="" data-hide-link-title="0">REcovery and SURvival of patients with moderate to severe acute REspiratory distress syndrome (ARDS) due to COVID-19: a multicentre, single-arm, Phase IV Itolizumab Trial: RESURRECT</a>
</div>
<div id="edit-subject" class="form-item form-item-label-before form-type-item">
  <label for="edit-subject">Message Subject </label>
 (Your Name) has forwarded a page to you from medRxiv
</div>
<div id="edit-body" class="form-item form-item-label-before form-type-item">
  <label for="edit-body">Message Body </label>
 (Your Name) thought you would like to see this page from the medRxiv website.
</div>
<div class="form-item form-item-label-before form-type-textarea form-item-message">
  <label for="edit-message--2">Your Personal Message </label>
 <div class="form-textarea-wrapper resizable"><textarea id="edit-message--2" name="message" cols="50" rows="10" class="form-textarea"></textarea></div>
</div>
<input type="hidden" name="path" value="node/426620" />
<input type="hidden" name="path_cid" value="" />
<input type="hidden" name="forward_footer" value=" " />
<input type="hidden" name="form_build_id" value="form-WqYpRToRCBZXjNxlLb158R9BkeuX_ZKySSSTIaMqey8" />
<input type="hidden" name="form_id" value="forward_form" />
<fieldset class="captcha form-wrapper"><legend><span class="fieldset-legend">CAPTCHA</span></legend><div class="fieldset-wrapper"><div class="fieldset-description">This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.</div><input type="hidden" name="captcha_sid" value="157694949" />
<input type="hidden" name="captcha_token" value="46d1932a6ef14e79e2d088442546b53b" />
<input type="hidden" name="captcha_response" value="Google no captcha" />
<div class="g-recaptcha" data-sitekey="6LfnJVIUAAAAAE-bUOMg0MJGki4lqSvDmhJp19fN" data-theme="light" data-type="image"></div></div></fieldset>
<div class="form-actions form-wrapper" id="edit-actions"><input type="submit" id="edit-submit" name="op" value="Send Message" class="form-submit" /></div></div></form>  </div>

  
  </div>
</div>
  </div>
</div>
</div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-share-link highwire_clipboard_link_ajax"  id="shareit">
  
      
  
  <div class="pane-content">
    <a href="/" class="link-icon"><span class="icon-share-alt"></span> <span class="title">Share</span></a>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-panels-mini pane-biorxiv-share highwire_clipboard_form_ajax_shareit" >
  
      
  
  <div class="pane-content">
    
<div class="panel-display omega-12-onecol" id="mini-panel-biorxiv_share">

		  <div class="panel-panel grid-12 panel-region-preface">
		  <div class="inside"><div class="panel-pane pane-highwire-article-citation" >
  
      
  
  <div class="pane-content">
    <div class="highwire-article-citation highwire-citation-type-highwire-article node426620--3" data-node-nid="426620" id="node426620--4106225512" data-pisa="medrxiv;2021.10.25.21265462v1" data-pisa-master="medrxiv;2021.10.25.21265462" data-seqnum="426620" data-apath="/medrxiv/early/2021/10/26/2021.10.25.21265462.atom"><div  class="highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-pap-list clearfix" >

      <div class="highwire-cite-title" >
      <div class="highwire-cite-title"><strong>RE</strong>covery and <strong>SUR</strong>vival of patients with moderate to severe acute <strong>RE</strong>spiratory distress syndrome (ARDS) due to <strong>C</strong>OVID-19: a multicentre, single-arm, Phase IV Itolizumab <strong>T</strong>rial: <strong>RESURRECT</strong></div>    </div>
  
      <div  class="highwire-cite-authors" ><span  class="highwire-citation-authors"><span class="highwire-citation-author first" data-delta="0"><span class="nlm-given-names">KR</span> <span class="nlm-surname">Raveendra</span></span>, <span class="highwire-citation-author" data-delta="1"><span class="nlm-given-names">Chirag</span> <span class="nlm-surname">Rathod</span></span>, <span class="highwire-citation-author" data-delta="2"><span class="nlm-given-names">Rahul</span> <span class="nlm-surname">Darnule</span></span>, <span class="highwire-citation-author" data-delta="3"><span class="nlm-given-names">Subramanian</span> <span class="nlm-surname">Loganathan</span></span>, <span class="highwire-citation-author" data-delta="4"><span class="nlm-given-names">Sarika</span> <span class="nlm-surname">Deodhar</span></span>, <span class="highwire-citation-author" data-delta="5"><span class="nlm-given-names">A</span> <span class="nlm-surname">Radhika</span></span>, <span class="highwire-citation-author" data-delta="6"><span class="nlm-given-names">Ashwani</span> <span class="nlm-surname">Marwah</span></span>, <span class="highwire-citation-author" data-delta="7"><span class="nlm-given-names">Nitin M</span> <span class="nlm-surname">Chaudhari</span></span>, <span class="highwire-citation-author" data-delta="8"><span class="nlm-given-names">Binay K</span> <span class="nlm-surname">Thakur</span></span>, <span class="highwire-citation-author" data-delta="9"><span class="nlm-given-names">Sivakumar</span> <span class="nlm-surname">Vaidyanathan</span></span>, <span class="highwire-citation-author" data-delta="10"><span class="nlm-given-names">Sandeep Nilkanth</span> <span class="nlm-surname">Athalye</span></span></span></div>
  
      <div  class="highwire-cite-metadata" ><span  class="highwire-cite-metadata-journal highwire-cite-metadata">medRxiv </span><span  class="highwire-cite-metadata-pages highwire-cite-metadata">2021.10.25.21265462; </span><span  class="highwire-cite-metadata-doi highwire-cite-metadata"><span class="doi_label">doi:</span> https://doi.org/10.1101/2021.10.25.21265462 </span></div>
  
  
  </div>
</div>  </div>

  
  </div>
</div>
	  </div>
	
  <div class="panel-panel grid-12 panel-region-content">
  	<div class="inside"><div class="panel-pane pane-highwire-article-clipboard-copy" >
  
      
  
  <div class="pane-content">
    <div class = "clipboard-copy">
  <span class="label-url">
    <label for="dynamic">Share This Article:</label>
  </span>
  <span class="input-text-url">
    <input type="text" id="dynamic" value="https://www.medrxiv.org/content/10.1101/2021.10.25.21265462v1" size="50"/>
  </span>
  <span class="copy-button button">
    <button id="copy-dynamic" class="clipboardjs-button" data-clipboard-target="#dynamic" data-clipboard-alert-style="tooltip" data-clipboard-alert-text="Copied!">Copy</button>
  </span>
</div>
  </div>

  
  </div>
</div>
  </div>
	
		  <div class="panel-panel grid-12 panel-region-postscript">
	    <div class="inside"><div class="panel-pane pane-service-links" >
  
      
  
  <div class="pane-content">
    <div class="service-links"><a href="http://digg.com/submit?phase=2&amp;url=https%3A//www.medrxiv.org/content/10.1101/2021.10.25.21265462v1&amp;title=REcovery%20and%20SURvival%20of%20patients%20with%20moderate%20to%20severe%20acute%20REspiratory%20distress%20syndrome%20%28ARDS%29%20due%20to%20COVID-19%3A%20a%20multicentre%2C%20single-arm%2C%20Phase%20IV%20Itolizumab%20Trial%3A%20RESURRECT" id="digg" title="Digg this post on digg.com" class="service-links-digg" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/digg.png" alt="Digg logo" /></a> <a href="http://reddit.com/submit?url=https%3A//www.medrxiv.org/content/10.1101/2021.10.25.21265462v1&amp;title=REcovery%20and%20SURvival%20of%20patients%20with%20moderate%20to%20severe%20acute%20REspiratory%20distress%20syndrome%20%28ARDS%29%20due%20to%20COVID-19%3A%20a%20multicentre%2C%20single-arm%2C%20Phase%20IV%20Itolizumab%20Trial%3A%20RESURRECT" id="reddit" title="Submit this post on reddit.com" class="service-links-reddit" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/reddit.png" alt="Reddit logo" /></a> <a href="http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.1101/2021.10.25.21265462v1&amp;text=REcovery%20and%20SURvival%20of%20patients%20with%20moderate%20to%20severe%20acute%20REspiratory%20distress%20syndrome%20%28ARDS%29%20due%20to%20COVID-19%3A%20a%20multicentre%2C%20single-arm%2C%20Phase%20IV%20Itolizumab%20Trial%3A%20RESURRECT" id="twitter" title="Share this on Twitter" class="service-links-twitter" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png" alt="Twitter logo" /></a> <a href="http://www.citeulike.org/posturl?url=https%3A//www.medrxiv.org/content/10.1101/2021.10.25.21265462v1&amp;title=REcovery%20and%20SURvival%20of%20patients%20with%20moderate%20to%20severe%20acute%20REspiratory%20distress%20syndrome%20%28ARDS%29%20due%20to%20COVID-19%3A%20a%20multicentre%2C%20single-arm%2C%20Phase%20IV%20Itolizumab%20Trial%3A%20RESURRECT" id="citeulike" title="Share on CiteULike" class="service-links-citeulike" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/citeyoulike.png" alt="CiteULike logo" /></a> <a href="http://www.facebook.com/sharer.php?u=https%3A//www.medrxiv.org/content/10.1101/2021.10.25.21265462v1&amp;t=REcovery%20and%20SURvival%20of%20patients%20with%20moderate%20to%20severe%20acute%20REspiratory%20distress%20syndrome%20%28ARDS%29%20due%20to%20COVID-19%3A%20a%20multicentre%2C%20single-arm%2C%20Phase%20IV%20Itolizumab%20Trial%3A%20RESURRECT" id="facebook" title="Share on Facebook" class="service-links-facebook" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png" alt="Facebook logo" /></a> <a href="http://www.google.com/bookmarks/mark?op=add&amp;bkmk=https%3A//www.medrxiv.org/content/10.1101/2021.10.25.21265462v1&amp;title=REcovery%20and%20SURvival%20of%20patients%20with%20moderate%20to%20severe%20acute%20REspiratory%20distress%20syndrome%20%28ARDS%29%20due%20to%20COVID-19%3A%20a%20multicentre%2C%20single-arm%2C%20Phase%20IV%20Itolizumab%20Trial%3A%20RESURRECT" id="google" title="Bookmark this post on Google" class="service-links-google" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/google-32.png" alt="Google logo" /></a> <a href="http://www.mendeley.com/import/?url=https%3A//www.medrxiv.org/content/10.1101/2021.10.25.21265462v1&amp;title=REcovery%20and%20SURvival%20of%20patients%20with%20moderate%20to%20severe%20acute%20REspiratory%20distress%20syndrome%20%28ARDS%29%20due%20to%20COVID-19%3A%20a%20multicentre%2C%20single-arm%2C%20Phase%20IV%20Itolizumab%20Trial%3A%20RESURRECT" id="mendeley" title="Share on Mendeley" class="service-links-mendeley" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png" alt="Mendeley logo" /></a></div>  </div>

  
  </div>
</div>
	  </div>
	
</div>
  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-minipanel-dialog-link pane-biorxiv-cite-tool" >
  
      
  
  <div class="pane-content">
    <div class='minipanel-dialog-wrapper'><div class='minipanel-dialog-link-link'><a href="/" oncontextmenu="javascript: return false;" class="minipanel-dialog-link-trigger link-icon" title="Citation Tools"><span class="icon-globe"></span> <span class="title">Citation Tools</span></a></div><div class='minipanel-dialog-link-mini' style='display:none'><div class="panel-display panel-1col clearfix" id="mini-panel-biorxiv_cite_tool">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-highwire-citation-export" >
  
      
  
  <div class="pane-content">
    <div class="highwire-citation-export">  
  <div class="highwire-citation-info">
      <div class="highwire-article-citation highwire-citation-type-highwire-article node426620--5" data-node-nid="426620" id="node426620--61520090535" data-pisa="medrxiv;2021.10.25.21265462v1" data-pisa-master="medrxiv;2021.10.25.21265462" data-seqnum="426620" data-apath="/medrxiv/early/2021/10/26/2021.10.25.21265462.atom"><div  class="highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-pap-list clearfix" >

      <div class="highwire-cite-title" >
      <div class="highwire-cite-title"><strong>RE</strong>covery and <strong>SUR</strong>vival of patients with moderate to severe acute <strong>RE</strong>spiratory distress syndrome (ARDS) due to <strong>C</strong>OVID-19: a multicentre, single-arm, Phase IV Itolizumab <strong>T</strong>rial: <strong>RESURRECT</strong></div>    </div>
  
      <div  class="highwire-cite-authors" ><span  class="highwire-citation-authors"><span class="highwire-citation-author first" data-delta="0"><span class="nlm-given-names">KR</span> <span class="nlm-surname">Raveendra</span></span>, <span class="highwire-citation-author" data-delta="1"><span class="nlm-given-names">Chirag</span> <span class="nlm-surname">Rathod</span></span>, <span class="highwire-citation-author" data-delta="2"><span class="nlm-given-names">Rahul</span> <span class="nlm-surname">Darnule</span></span>, <span class="highwire-citation-author" data-delta="3"><span class="nlm-given-names">Subramanian</span> <span class="nlm-surname">Loganathan</span></span>, <span class="highwire-citation-author" data-delta="4"><span class="nlm-given-names">Sarika</span> <span class="nlm-surname">Deodhar</span></span>, <span class="highwire-citation-author" data-delta="5"><span class="nlm-given-names">A</span> <span class="nlm-surname">Radhika</span></span>, <span class="highwire-citation-author" data-delta="6"><span class="nlm-given-names">Ashwani</span> <span class="nlm-surname">Marwah</span></span>, <span class="highwire-citation-author" data-delta="7"><span class="nlm-given-names">Nitin M</span> <span class="nlm-surname">Chaudhari</span></span>, <span class="highwire-citation-author" data-delta="8"><span class="nlm-given-names">Binay K</span> <span class="nlm-surname">Thakur</span></span>, <span class="highwire-citation-author" data-delta="9"><span class="nlm-given-names">Sivakumar</span> <span class="nlm-surname">Vaidyanathan</span></span>, <span class="highwire-citation-author" data-delta="10"><span class="nlm-given-names">Sandeep Nilkanth</span> <span class="nlm-surname">Athalye</span></span></span></div>
  
      <div  class="highwire-cite-metadata" ><span  class="highwire-cite-metadata-journal highwire-cite-metadata">medRxiv </span><span  class="highwire-cite-metadata-pages highwire-cite-metadata">2021.10.25.21265462; </span><span  class="highwire-cite-metadata-doi highwire-cite-metadata"><span class="doi_label">doi:</span> https://doi.org/10.1101/2021.10.25.21265462 </span></div>
  
  
  </div>
</div>  </div>
  <div class="highwire-citation-formats">
  	      <h2>Citation Manager Formats</h2>
        <div class="highwire-citation-formats-links">
      <span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.spage&amp;rft.epage&amp;rft.atitle=REcovery%20and%20SURvival%20of%20patients%20with%20moderate%20to%20severe%20acute%20REspiratory%20distress%20syndrome%20%28ARDS%29%20due%20to%20COVID-19%3A%20a%20multicentre%2C%20single-arm%2C%20Phase%20IV%20Itolizumab%20Trial%3A%20RESURRECT&amp;rft.volume&amp;rft.issue&amp;rft.date=2021-01-01%2000%3A00%3A00&amp;rft.stitle&amp;rft.jtitle=medRxiv&amp;rft.au=Raveendra%2C+KR&amp;rft.au=Rathod%2C+Chirag&amp;rft.au=Darnule%2C+Rahul&amp;rft.au=Loganathan%2C+Subramanian&amp;rft.au=Deodhar%2C+Sarika&amp;rft.au=Radhika%2C+A&amp;rft.au=Marwah%2C+Ashwani&amp;rft.au=Chaudhari%2C+Nitin+M&amp;rft.au=Thakur%2C+Binay+K&amp;rft.au=Vaidyanathan%2C+Sivakumar&amp;rft.au=Athalye%2C+Sandeep+Nilkanth"></span><ul class="hw-citation-links inline button button-alt button-grid clearfix"><li class="bibtext first"><a href="/highwire/citation/426620/bibtext" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">BibTeX</a></li><li class="bookends"><a href="/highwire/citation/426620/bookends" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Bookends</a></li><li class="easybib"><a href="/highwire/citation/426620/easybib" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">EasyBib</a></li><li class="endnote-tagged"><a href="/highwire/citation/426620/endnote-tagged" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">EndNote (tagged)</a></li><li class="endnote-8-xml"><a href="/highwire/citation/426620/endnote-8-xml" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">EndNote 8 (xml)</a></li><li class="medlars"><a href="/highwire/citation/426620/medlars" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Medlars</a></li><li class="mendeley"><a href="/highwire/citation/426620/mendeley" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Mendeley</a></li><li class="papers"><a href="/highwire/citation/426620/papers" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Papers</a></li><li class="refworks-tagged"><a href="/highwire/citation/426620/refworks-tagged" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">RefWorks Tagged</a></li><li class="reference-manager"><a href="/highwire/citation/426620/reference-manager" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Ref Manager</a></li><li class="ris"><a href="/highwire/citation/426620/ris" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">RIS</a></li><li class="zotero last"><a href="/highwire/citation/426620/zotero" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Zotero</a></li></ul>    </div>
  </div>
</div>
  </div>

  
  </div>
</div>
  </div>
</div>
</div></div>  </div>

  
  </div>
</div>
          </div>
        </div>
	</div> <!-- /.panel-row-wrapper -->	
	
	</div>

  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-service-links" >
  
      
  
  <div class="pane-content">
    <div class="service-links"><div class="item-list"><ul><li class="first"><a href="http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.1101/2021.10.25.21265462v1&amp;count=horizontal&amp;via=&amp;text=REcovery%20and%20SURvival%20of%20patients%20with%20moderate%20to%20severe%20acute%20REspiratory%20distress%20syndrome%20%28ARDS%29%20due%20to%20COVID-19%3A%20a%20multicentre%2C%20single-arm%2C%20Phase%20IV%20Itolizumab%20Trial%3A%20RESURRECT&amp;counturl=https%3A//www.medrxiv.org/content/10.1101/2021.10.25.21265462v1" class="twitter-share-button service-links-twitter-widget" id="twitter_widget" title="Tweet This" rel="nofollow" data-icon-position="" data-hide-link-title="0"><span class="element-invisible">Tweet Widget</span></a></li><li><a href="http://www.facebook.com/plugins/like.php?href=https%3A//www.medrxiv.org/content/10.1101/2021.10.25.21265462v1&amp;layout=button_count&amp;show_faces=false&amp;action=like&amp;colorscheme=light&amp;width=100&amp;height=21&amp;font=&amp;locale=" id="facebook_like" title="I Like it" class="service-links-facebook-like" rel="nofollow" data-icon-position="" data-hide-link-title="0"><span class="element-invisible">Facebook Like</span></a></li><li class="last"><a href="https://www.medrxiv.org/content/10.1101/2021.10.25.21265462v1" id="google_plus_one" title="Plus it" class="service-links-google-plus-one" rel="nofollow" data-icon-position="" data-hide-link-title="0"><span class="element-invisible">Google Plus One</span></a></li></ul></div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-article-collections" >
  
        <h2 class="pane-title">Subject Area</h2>
    
  
  <div class="pane-content">
    <div class="highwire-list-wrapper highwire-article-collections"><div class="highwire-list"><ul class="highwire-article-collection-term-list"><li class="first last odd"><span class="highwire-article-collection-term"><a href="/collection/emergency-medicine" class="highlight" data-icon-position="" data-hide-link-title="0">Emergency Medicine<i class="icon-caret-right"></i>
</a></span></li></ul></div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-panels-mini pane-biorxiv-subject-collections block-style-col2" >
  
      
  
  <div class="pane-content">
    <div class="panel-flexible panels-flexible-8 clearfix" id="mini-panel-biorxiv_subject_collections">
<div class="panel-flexible-inside panels-flexible-8-inside">
<div class="panels-flexible-region panels-flexible-region-8-center panels-flexible-region-first panels-flexible-region-last">
  <div class="inside panels-flexible-region-inside panels-flexible-region-8-center-inside panels-flexible-region-inside-first panels-flexible-region-inside-last">
<div class="panel-pane pane-snippet" >
  
      
  
  <div class="pane-content">
    <div class="snippet biorxiv-subject-areas-table-title" id="biorxiv-subject-areas-table-title">
  
      
  <div class="snippet-content">
    <b>Subject Areas</b>  </div>

</div>
  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-snippet" >
  
      
  
  <div class="pane-content">
    <div class="snippet biorxiv-subject-areas-view-papers" id="biorxiv-subject-areas-view-papers">
  
      
  <div class="snippet-content">
    <a href="/content/early/recent"><strong>All Articles</strong></a>  </div>

</div>
  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-subject-collections" >
  
      
  
  <div class="pane-content">
    <ul id="collection" class="collection highwire-list-expand"><li class="outer collection depth-2  child first"><div class = "data-wrapper"><a href="/collection/addiction-medicine" class="" data-icon-position="" data-hide-link-title="0">Addiction Medicine</a> <span class = "article-count">(111)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/allergy-and-immunology" class="" data-icon-position="" data-hide-link-title="0">Allergy and Immunology</a> <span class = "article-count">(299)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/anesthesia" class="" data-icon-position="" data-hide-link-title="0">Anesthesia</a> <span class = "article-count">(75)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/cardiovascular-medicine" class="" data-icon-position="" data-hide-link-title="0">Cardiovascular Medicine</a> <span class = "article-count">(665)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/dentistry-and-oral-medicine" class="" data-icon-position="" data-hide-link-title="0">Dentistry and Oral Medicine</a> <span class = "article-count">(121)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/dermatology" class="" data-icon-position="" data-hide-link-title="0">Dermatology</a> <span class = "article-count">(77)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/emergency-medicine" class="" data-icon-position="" data-hide-link-title="0">Emergency Medicine</a> <span class = "article-count">(216)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease" class="" data-icon-position="" data-hide-link-title="0">Endocrinology (including Diabetes Mellitus and Metabolic Disease)</a> <span class = "article-count">(299)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/epidemiology" class="" data-icon-position="" data-hide-link-title="0">Epidemiology</a> <span class = "article-count">(7268)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/forensic-medicine" class="" data-icon-position="" data-hide-link-title="0">Forensic Medicine</a> <span class = "article-count">(4)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/gastroenterology" class="" data-icon-position="" data-hide-link-title="0">Gastroenterology</a> <span class = "article-count">(306)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/genetic-and-genomic-medicine" class="" data-icon-position="" data-hide-link-title="0">Genetic and Genomic Medicine</a> <span class = "article-count">(1295)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/geriatric-medicine" class="" data-icon-position="" data-hide-link-title="0">Geriatric Medicine</a> <span class = "article-count">(126)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/health-economics" class="" data-icon-position="" data-hide-link-title="0">Health Economics</a> <span class = "article-count">(308)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/health-informatics" class="" data-icon-position="" data-hide-link-title="0">Health Informatics</a> <span class = "article-count">(1004)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/health-policy" class="" data-icon-position="" data-hide-link-title="0">Health Policy</a> <span class = "article-count">(526)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/health-systems-and-quality-improvement" class="" data-icon-position="" data-hide-link-title="0">Health Systems and Quality Improvement</a> <span class = "article-count">(359)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/hematology" class="" data-icon-position="" data-hide-link-title="0">Hematology</a> <span class = "article-count">(151)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/hiv-aids" class="" data-icon-position="" data-hide-link-title="0">HIV/AIDS</a> <span class = "article-count">(287)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/infectious_diseases" class="" data-icon-position="" data-hide-link-title="0">Infectious Diseases (except HIV/AIDS)</a> <span class = "article-count">(8512)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/intensive-care-and-critical-care-medicine" class="" data-icon-position="" data-hide-link-title="0">Intensive Care and Critical Care Medicine</a> <span class = "article-count">(483)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/medical-education" class="" data-icon-position="" data-hide-link-title="0">Medical Education</a> <span class = "article-count">(160)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/medical-ethics" class="" data-icon-position="" data-hide-link-title="0">Medical Ethics</a> <span class = "article-count">(40)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/nephrology" class="" data-icon-position="" data-hide-link-title="0">Nephrology</a> <span class = "article-count">(153)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/neurology" class="" data-icon-position="" data-hide-link-title="0">Neurology</a> <span class = "article-count">(1239)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/nursing" class="" data-icon-position="" data-hide-link-title="0">Nursing</a> <span class = "article-count">(63)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/nutrition" class="" data-icon-position="" data-hide-link-title="0">Nutrition</a> <span class = "article-count">(200)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/obstetrics-and-gynecology" class="" data-icon-position="" data-hide-link-title="0">Obstetrics and Gynecology</a> <span class = "article-count">(255)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/occupational-and-environmental-health" class="" data-icon-position="" data-hide-link-title="0">Occupational and Environmental Health</a> <span class = "article-count">(368)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/oncology" class="" data-icon-position="" data-hide-link-title="0">Oncology</a> <span class = "article-count">(702)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/ophthalmology" class="" data-icon-position="" data-hide-link-title="0">Ophthalmology</a> <span class = "article-count">(217)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/orthopedics" class="" data-icon-position="" data-hide-link-title="0">Orthopedics</a> <span class = "article-count">(70)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/otolaryngology" class="" data-icon-position="" data-hide-link-title="0">Otolaryngology</a> <span class = "article-count">(139)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/pain-medicine" class="" data-icon-position="" data-hide-link-title="0">Pain Medicine</a> <span class = "article-count">(73)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/palliative-medicine" class="" data-icon-position="" data-hide-link-title="0">Palliative Medicine</a> <span class = "article-count">(30)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/pathology" class="" data-icon-position="" data-hide-link-title="0">Pathology</a> <span class = "article-count">(195)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/pediatrics" class="" data-icon-position="" data-hide-link-title="0">Pediatrics</a> <span class = "article-count">(410)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/pharmacology-and-therapeutics" class="" data-icon-position="" data-hide-link-title="0">Pharmacology and Therapeutics</a> <span class = "article-count">(195)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/primary-care-research" class="" data-icon-position="" data-hide-link-title="0">Primary Care Research</a> <span class = "article-count">(158)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/psychiatry-and-clinical-psychology" class="" data-icon-position="" data-hide-link-title="0">Psychiatry and Clinical Psychology</a> <span class = "article-count">(1369)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/public-and-global-health" class="" data-icon-position="" data-hide-link-title="0">Public and Global Health</a> <span class = "article-count">(3057)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/radiology-and-imaging" class="" data-icon-position="" data-hide-link-title="0">Radiology and Imaging</a> <span class = "article-count">(509)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/rehabilitation-medicine-and-physical-therapy" class="" data-icon-position="" data-hide-link-title="0">Rehabilitation Medicine and Physical Therapy</a> <span class = "article-count">(244)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/respiratory-medicine" class="" data-icon-position="" data-hide-link-title="0">Respiratory Medicine</a> <span class = "article-count">(415)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/rheumatology" class="" data-icon-position="" data-hide-link-title="0">Rheumatology</a> <span class = "article-count">(158)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/sexual-and-reproductive-health" class="" data-icon-position="" data-hide-link-title="0">Sexual and Reproductive Health</a> <span class = "article-count">(118)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/sports-medicine" class="" data-icon-position="" data-hide-link-title="0">Sports Medicine</a> <span class = "article-count">(115)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/surgery" class="" data-icon-position="" data-hide-link-title="0">Surgery</a> <span class = "article-count">(153)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/toxicology" class="" data-icon-position="" data-hide-link-title="0">Toxicology</a> <span class = "article-count">(32)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/transplantation" class="" data-icon-position="" data-hide-link-title="0">Transplantation</a> <span class = "article-count">(67)</span></div></li>
<li class="outer collection depth-2  child last"><div class = "data-wrapper"><a href="/collection/urology" class="" data-icon-position="" data-hide-link-title="0">Urology</a> <span class = "article-count">(51)</span></div></li>
</ul>  </div>

  
  </div>
  </div>
</div>
</div>
</div>
  </div>

  
  </div>
</div>
			</div>
		</div>
	
	</div> <!-- /.panel-row-wrapper -->	
	
	</div>

    </div>
  </div>
</div>      </div>
</div>  </div>
</section>    
  
  </div>    <div class="region region-page-bottom" id="region-page-bottom">
  <div class="region-inner region-page-bottom-inner">
      </div>
</div><script type="text/javascript" src="https://www.medrxiv.org/sites/default/files/advagg_js/js__Vh5BcRYb6VtLoN3uam6O4DIKltYUVMjVDWtakoysPq0__Wed8jsPTirEozek7dWSCS8970Cp7a9xKKgFk6FPuSVM__OWu9jWxbqz5eMqeTDc4xZhOzPlgoEqGh5PmxOqlf8ZY.js"></script>
<script type="text/javascript" src="https://d33xdlntwy0kbs.cloudfront.net/cshl_custom_medrxiv.js"></script>
<script type="text/javascript" src="https://www.medrxiv.org/sites/default/files/advagg_js/js__BmqjBnkz3MgYCAoc25s1lDRMEjLhC3mEPVonUFIHi08__Unwv5-ZIuHBfFwytsjEx1niBVJ7n1T4lPws7VrkHXM4__OWu9jWxbqz5eMqeTDc4xZhOzPlgoEqGh5PmxOqlf8ZY.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
function euCookieComplianceLoadScripts() {}
//--><!]]>
</script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
var eu_cookie_compliance_cookie_name = "";
//--><!]]>
</script>
  </body>
</html>
